name: Glasgow Coma Scale-NINDS Version 1.0 - Confounder: GCS Accurate


name: Glasgow Coma Scale-NINDS Version 1.0 - Confounder: Paralytic


name: Glasgow Coma Scale-NINDS Version 1.0 - Confounder: Alcohol or Drug of Abuse


name: Glasgow Coma Scale-NINDS Version 1.0 - Confounder: C-Spine Injury


name: Glasgow Coma Scale-NINDS Version 1.0 - Confounder: Hypoxia or Hypotension


name: Glasgow Coma Scale-NINDS Version 1.0 - Confounder: Hypothermia


name: Glasgow Coma Scale-NINDS Version 1.0 - Confounder: Sedation


name: Glasgow Coma Scale-NINDS Version 1.0 - Confounder: Unknown


name: PASI Feldman Version Clinical Classification Question


name: Psoriasis Area and Severity Index Feldman Version Clinical Classification


name: CD80 Cell Surface Expression Measurement


name: CD83 Cell Surface Expression Measurement


name: CD95 Cell Surface Expression Measurement


name: HLA-DR Cell Surface Expression Measurement


name: Percent of Positive Tumor Infiltrating Immune Cells


name: Percent of Positive Tumor Infiltrating Lymphocytes


name: Neuro-QOL Item Bank v2.0 Cognitive Function


name: How Much Current Difficulty Keeping Track of Time


name: How Much Current Difficulty Checking Accuracy of Financial Documents


name: How Much Current Difficulty Planning Activity Several Days in Advance


name: How Much Current Difficulty Getting Things Organized


name: How Much Current Difficulty Remembering Where Things Were Placed or Stored


name: How Much Current Difficulty Remembering Errands Without Writing them Down


name: How Often Make Simple Mistakes More Easily


name: How Often Words Seemed on the Tip of Tongue


name: How Often Had Trouble Keeping Track if Interrupted


name: How Often Had Difficulty Doing More than One Task Concurrently


name: How Often Had Trouble Remembering Whether I Did Things I was Supposed to


name: How Often Had Trouble Remembering New Information


name: How Often Walked into Room and Forgot Reason


name: How Often Had Trouble Remembering Name of Familiar Person


name: How Often Reacted Slowly to Things Said or Done


name: How Often Had Trouble Starting on Very Simple Tasks


name: How Often Had Trouble Planning Steps of Task


name: MRI-guided Intensity-Modulated Radiation Therapy


name: EndoPredict Breast Cancer Prognostic Test


name: Ophthalmic Tomography B-Scan Volume Analysis


name: Outsourcing Facility Compounded Human Drug Product (Not Marketed - Not Distributed)


name: MYCL Messenger RNA Expression Measurement


name: CDISC SDTM Auricular Findings Test Name Terminology


name: CDISC SDTM Auricular Findings Test Code Terminology


name: CDISC SDTM Pediatric Findings About Test Name Terminology


name: CDISC SDTM Pediatric Findings About Test Code Terminology


name: CDISC Protocol Study Activity Attribute Terminology


name: CDISC Clinical Classification Harvey-Bradshaw Index HBI0101 Standardized Character Response Terminology


name: CDISC Clinical Classification Harvey-Bradshaw Index HBI0102 Original Response Terminology


name: CDISC Clinical Classification Harvey-Bradshaw Index HBI0102 Standardized Character Response Terminology


name: CDISC Clinical Classification Harvey-Bradshaw Index HBI0104 Original Response Terminology


name: CDISC Clinical Classification Harvey-Bradshaw Index HBI0104 Standardized Character Response Terminology


name: CDISC Clinical Classification Harvey-Bradshaw Index HBI0105A Through HBI0105H Original Response Terminology


name: CDISC Clinical Classification Harvey-Bradshaw Index HBI0105A Through HBI0105H Standardized Character Response Terminology


name: CDISC Clinical Classification Modified Van Assche Index MVAI101 Original Response Terminology


name: CDISC Clinical Classification Modified Van Assche Index MVAI101 Standardized Character Response Terminology


name: CDISC Clinical Classification Modified Van Assche Index MVAI102 Original Response Terminology


name: CDISC Clinical Classification Modified Van Assche Index MVAI102 Standardized Character Response Terminology


name: CDISC Clinical Classification Modified Van Assche Index MVAI103 Original Response Terminology


name: CDISC Clinical Classification Modified Van Assche Index MVAI103 Standardized Character Response Terminology


name: CDISC Clinical Classification Modified Van Assche Index MVAI104 Original Response Terminology


name: CDISC Clinical Classification Modified Van Assche Index MVAI104 Standardized Character Response Terminology


name: CDISC Clinical Classification Modified Van Assche Index MVAI105 Original Response Terminology


name: CDISC Clinical Classification Modified Van Assche Index MVAI105 Standardized Character Response Terminology


name: CDISC Clinical Classification Rutgeerts Score RUTG0101 Original Response Terminology


name: CDISC Clinical Classification Rutgeerts Score RUTG0101 Standardized Character Response Terminology


name: CDISC Clinical Classification Harvey-Bradshaw Index Test Name Terminology


name: CDISC Clinical Classification Harvey-Bradshaw Index Test Code Terminology


name: CDISC Clinical Classification Montreal Classification for Crohn's Disease Test Name Terminology


name: CDISC Clinical Classification Montreal Classification for Crohn's Disease Test Code Terminology


name: CDISC Clinical Classification Modified Van Assche Index Test Name Terminology


name: CDISC Clinical Classification Modified Van Assche Index Test Code Terminology


name: CDISC Clinical Classification Rutgeerts Score Test Name Terminology


name: CDISC Clinical Classification Rutgeerts Score Test Code Terminology


name: CDISC Clinical Classification Psoriasis Area and Severity Index Fredriksson Version Test Name Terminology


name: CDISC Clinical Classification Psoriasis Area and Severity Index Fredriksson Version Test Code Terminology


name: CDISC Clinical Classification Psoriasis Area and Severity Index European Medical Agency Version Test Name Terminology


name: CDISC Clinical Classification Psoriasis Area and Severity Index European Medical Agency Version Test Code Terminology


name: CDISC Clinical Classification Psoriasis Area and Severity Index Bozek Version Test Name Terminology


name: CDISC Clinical Classification Psoriasis Area and Severity Index Bozek Version Test Code Terminology


name: CDISC Questionnaire Patient Health Questionnaire - 8 Item Test Name Terminology


name: CDISC Questionnaire Patient Health Questionnaire - 8 Item Test Code Terminology


name: CDISC Questionnaire Voice Handicap Index Test Name Terminology


name: CDISC Questionnaire Voice Handicap Index Test Code Terminology


name: Harvey-Bradshaw Index Clinical Classification Question


name: Montreal Classification for Crohn's Disease Clinical Classification Question


name: Modified Van Assche Index Clinical Classification Question


name: Psoriasis Area and Severity Index Fredriksson Version Clinical Classification Question


name: Psoriasis Area and Severity Index European Medical Agency Version Clinical Classification Question


name: Psoriasis Area and Severity Index Bozek Version Clinical Classification Question


name: The Patient Health Questionnaire - 8 Item Questionnaire Question


name: Voice Handicap Index Questionnaire Question


name: Harvey-Bradshaw Index Clinical Classification


name: Montreal Classification for Crohn's Disease Clinical Classification


name: Modified Van Assche Index Clinical Classification


name: Psoriasis Area and Severity Index Fredriksson Version Clinical Classification


name: Psoriasis Area and Severity Index European Medical Agency Version Clinical Classification


name: Psoriasis Area and Severity Index Bozek Version Clinical Classification


name: HBI - Complication: Pyoderma Gangrenosum


name: Montreal Classification - Age at Diagnosis


name: MVAI - Hyperintensity T2-weighted Images


name: PHQ-8 - Little Interest or Pleasure in Things


name: PHQ-8 - Feeling Down Depressed or Hopeless


name: PHQ-8 - Trouble Falling or Staying Asleep


name: PHQ-8 - Moving Slowly or Fidgety or Restless


name: VHI - People Difficulty Understanding Me


name: VHI - Speak Friends Less Often Because Voice


name: VHI - Left Out of Conversation Because Voice


name: VHI - People Ask What's Wrong With Voice


name: VHI - Tense Talking to Others Because Voice


name: VHI - People Seem Irritated With My Voice


name: VHI - People Don't Understand Voice Problem


name: VHI - Less Outgoing Because of Voice Problem


name: ACC-AHA Cardiovascular and Noncardiovascular Complications of COVID-19 Terminology


name: Stem Cell Memory Cytotoxic T-Lymphocyte Subpopulation to Cytotoxic T-Lymphocyte Ratio Measurement


name: Helper 17.1 T-Lymphocyte Subpopulation to Helper T-Lymphocyte Ratio Measurement


name: Regulatory Cytotoxic T-Lymphocyte Subpopulation to Cytotoxic T-Lymphocyte Ratio Measurement


name: Central Memory Helper T-Lymphocyte Subpopulation to Helper T-Lymphocyte Ratio Measurement


name: Follicular Helper T-Lymphocyte Subpopulation to Helper T-Lymphocyte Ratio Measurement


name: Regulatory Helper T-Lymphocyte Subpopulation to Helper T-Lymphocyte Ratio Measurement


name: CEA Cell Adhesion Molecule 5 Measurement


name: Bioresearch Monitoring Technical Conformance Guide


name: Stem Cell Memory Cytotoxic T-Lymphocyte to Cytotoxic T-Lymphocyte Ratio Measurement


name: Stem Cell Memory Cytotoxic T-Lymphocyte to Naive Cytotoxic T-Lymphocyte Ratio Measurement


name: Terminal Memory Cytotoxic T-Lymphocyte Subpopulation to Cytotoxic T-Lymphocyte Ratio Measurement


name: CD278 Cell Surface Expression Measurement


name: CD279 Cell Surface Expression Measurement


name: Ki67 Cell Surface Expression Measurement


name: Helper 17.1 T-Lymphocyte Subpopulation to Helper 17.1 T-Lymphocyte Ratio Measurement


name: Helper 17.1 T-Lymphocyte to Helper T-Lymphocyte Ratio Measurement


name: Helper 17 T-Lymphocyte Subpopulation to Helper 17 T-Lymphocyte Ratio Measurement


name: Helper 17 T-Lymphocyte Subpopulation to Helper T-Lymphocyte Ratio Measurement


name: Helper 17 T-Lymphocyte to Helper T-Lymphocyte Ratio Measurement


name: Helper 1 T-Lymphocyte Subpopulation to Helper 1 T-Lymphocyte Ratio Measurement


name: Helper 1 T-Lymphocyte Subpopulation to Helper T-Lymphocyte Ratio Measurement


name: Helper 1 T-Lymphocyte to Helper T-Lymphocyte Ratio Measurement


name: Helper 22 T-Lymphocyte Subpopulation to Helper 22 T-Lymphocyte Ratio Measurement


name: Helper 22 T-Lymphocyte Subpopulation to Helper T-Lymphocyte Ratio Measurement


name: Helper 22 T-Lymphocyte to Helper T-Lymphocyte Ratio Measurement


name: Helper 2 T-Lymphocyte Subpopulation to Helper 2 T-Lymphocyte Ratio Measurement


name: Helper 2 T-Lymphocyte Subpopulation to Helper T-Lymphocyte Ratio Measurement


name: Helper 2 T-Lymphocyte to Helper T-Lymphocyte Ratio Measurement


name: Helper 9 T-Lymphocyte Subpopulation to Helper 9 T-Lymphocyte Ratio Measurement


name: Helper 9 T-Lymphocyte Subpopulation to Helper T-Lymphocyte Ratio Measurement


name: Helper 9 T-Lymphocyte to Helper T-Lymphocyte Ratio Measurement


name: Naive Helper Regulatory T-Lymphocyte Subpopulation to Helper Regulatory T-Lymphocyte Ratio Measurement


name: Stem Cell Memory Helper T-Lymphocyte Subpopulation to Helper T-Lymphocyte Ratio Measurement


name: Stem Cell Memory Helper T-Lymphocyte Subpopulation to Naive Helper T-Lymphocyte Ratio Measurement


name: Effector Memory Cytotoxic T-Lymphocyte to Cytotoxic T-Lymphocyte Ratio Measurement


name: Cytotoxic T-Lymphocytes to Lymphocytes Ratio Measurement


name: Naive Cytotoxic T-Lymphocyte to Cytotoxic T-Lymphocyte Ratio Measurement


name: Regulatory Cytotoxic T-Lymphocyte Subpopulation to Regulatory Cytotoxic T-Lymphocyte Ratio Measurement


name: Regulatory Cytotoxic T-Lymphocyte to Cytotoxic T-Lymphocyte Ratio Measurement


name: Stem Cell Memory Cytotoxic T-Lymphocyte Count


name: Stem Cell Memory Cytotoxic T-Lymphocyte Subpopulation Count


name: Stem Cell Memory Cytotoxic T-Lymphocyte Subpopulation to Stem Cell Memory Cytotoxic T-Lymphocyte Ratio Measurement


name: Cytotoxic T-Lymphocyte Subpopulation to T-Lymphocyte Ratio Measurement


name: Central Memory Helper T-Lymphocyte Subpopulation to Central Memory Helper T-Lymphocyte Ratio Measurement


name: Central Memory Helper T-Lymphocyte to Helper T-Lymphocyte Ratio Measurement


name: Effector Memory Helper T-Lymphocyte Subpopulation to Effector Memory Helper T-Lymphocyte Ratio Measurement


name: Effector Memory Helper T-Lymphocyte Subpopulation to Helper T-Lymphocyte Ratio Measurement


name: Effector Memory Helper T-Lymphocyte to Helper T-Lymphocyte Ratio Measurement


name: Follicular Helper T-Lymphocyte Subpopulation Count


name: Follicular Helper T-Lymphocyte Subpopulation to Follicular Helper T-Lymphocyte Ratio Measurement


name: Follicular Helper T-Lymphocyte to Helper T-Lymphocyte Ratio Measurement


name: Helper T-Lymphocyte to Lymphocyte Ratio Measurement


name: Memory Helper T-Lymphocyte Subpopulation to Helper T-Lymphocyte Ratio Measurement


name: Naive Helper T-Lymphocyte Subpopulation to Naive Helper T-Lymphocyte Ratio Measurement


name: Naive Helper T-Lymphocyte Subpopulation to Helper T-Lymphocyte Ratio Measurement


name: Naive Helper T-Lymphocyte to Helper T-Lymphocyte Ratio Measurement


name: Regulatory Memory Helper T-Lymphocyte Subpopulation to Regulatory Memory Helper T-Lymphocyte Ratio Measurement


name: Regulatory Memory Helper T-Lymphocyte to Regulatory Helper T-Lymphocyte Ratio Measurement


name: Naive Regulatory Helper T-Lymphocyte Subpopulation to Naive Regulatory Helper T-Lymphocyte Ratio Measurement


name: Naive Regulatory Helper T-Lymphocyte to Regulatory Helper T-Lymphocyte Ratio Measurement


name: Regulatory Helper T-Lymphocyte Subpopulation to Regulatory Helper T-Lymphocyte Ratio Measurement


name: Eighty Percent Neutralization Endpoint Titer


name: Fifty Percent Plaque Reduction Neutralization Endpoint Titer


name: Fifty Percent Focus Reduction Neutralization Titer


name: Lysosome-Associated Membrane Protein 2 Measurement


name: Lysosomal Associated Membrane Protein 2 to Glyceraldehyde-3-Phosphate Dehydrogenase Ratio Measurement


name: Soluble CEA Cell Adhesion Molecule 5 Measurement


name: Wild Type Huntingtin Protein Measurement


name: Synoviocytes to Leukocytes Ratio Measurement


name: Acinetobacter calcoaceticus/baumannii Complex DNA Measurement


name: Acinetobacter calcoaceticus/baumannii Complex Measurement


name: Enterobacter cloacae Complex DNA Measurement


name: Enterobacter cloacae Complex Measurement


name: Human Parainfluenza virus RNA Measurement


name: Hematopoietic Cells to Adipocytes Ratio Measurement


name: MDS/MPN IWC Savona 2015 Oncology Response Criteria


name: Elapsed Time Since Last Menstrual Period


name: Spot Forming Units Per Ten Thousand Peripheral Blood Mononuclear Cells


name: Spot Forming Units Per Twenty Thousand Peripheral Blood Mononuclear Cells


name: Extracellular Water to Total Body Water Ratio Measurement


name: Appendix 3: COVID-19 Diagnosis Terminology


name: Appendix 4: COVID-19 Cardiovascular Complications Terminology


name: Appendix 5: COVID-19 Noncardiovascular Complications Terminology


name: Appendix 6: Symptoms and Signs Terminology


name: Appendix 7: Diagnostic Procedures Terminology


name: Appendix 8: Pharmacological Therapy Terminology


name: Appendix 9: Therapeutic and Supportive Procedures for COVID-19 Terminology


name: Appendix 10: End-of-Life Management Terminology


name: Acute Cardiovascular Complications Related to COVID-19 Infection Terminology


name: Cardiovascular Mortality During Acute COVID-19 Infection Terminology


name: Current Symptoms and Signs: Clinical Symptoms Terminology


name: Invasive Coronary/Vascular/Neurovascular Revascularization Treatment Terminology


name: Postacute Cardiovascular Sequelae of SARS-CoV-2 Infection or Long-Term Cardiovascular Complications of COVID-19 Terminology


name: Therapies for Preexisting Cardiovascular Disease (Patient Taking Prior to Admission) Terminology


name: Therapies for Supportive Care During COVID-19 Infection Terminology


name: COVID-19-specific Anticoagulation Dosing Strategy


name: Implantation of Long Term Durable Mechanical Circulatory Support Device


name: Implantation of Temporary Mechanical Circulatory Support Device


name: Temporary Transvenous Pacing Wire Placement


name: Preexisting Cardiovascular Disease Therapy


name: Type of Permanent Cardioverter-Defibrillator Implanted


name: COVID-19-specific Full Anticoagulation Dose


name: COVID-19-specific Intermediate Anticoagulation Dose


name: Date of Cardiopulmonary Resuscitation for Cardiac Arrest


name: Date of First COVID-19-related Hospitalization


name: Date of First Hospitalization with Incidental Diagnosis of SARS-CoV-2 Infection


name: Date of Cardioverter-Defibrillator Implantation


name: Date of Percutaneous Coronary Intervention


name: Date of Temporary Transvenous Pacing Wire Insertion


name: Bioabsorbable Polymer-Coated Drug Eluting Stent


name: Hospitalization with Incidental Diagnosis of SARS-CoV-2 Infection


name: Manufacturer of SARS-CoV-2 Vaccine Received


name: Percutaneous Coronary Intervention Status


name: Salvage Percutaneous Coronary Intervention


name: Urgent Percutaneous Coronary Intervention


name: Catheter-based Miniaturized Left Ventricular Assist Device


name: Thrombectomy for Peripheral Arterial Thrombus


name: Time of Cardiopulmonary Resuscitation for Cardiac Arrest


name: Time of Percutaneous Coronary Intervention


name: ACC-AHA COVID-19 Appendix Authorized Values


name: Regimen Used to Treat Appendiceal Cancer


name: Regimen Used to Treat Salivary Gland Tumor


name: Dose-dense AC Followed by Dose-Dense Paclitaxel/Trastuzumab Regimen


name: Regimen Used to Treat Pre-malignant Disorder


name: Therapeutic Globin Gene Level Expression Analysis


name: Three-Dimensional Dynamic Intensity Entropy Transformation Magnetic Resonance Imaging


name: Neuro QOL Item Bank v2.0 - Pediatric Cognitive Function


name: Have Trouble Paying Attention to Teacher


name: Have to Work Hard to Pay Attention or Will Make a Mistake


name: Bevacizumab/Cisplatin/Pemetrexed Followed by Bevacizumab Regimen


name: Bevacizumab/Carboplatin/Pemetrexed Followed by Bevacizumab Regimen


name: Neuro QOL Pediatric Mental Health Domain


name: Could Do Sports and Exercise Other Kids Same Age Could Do


name: Physically Able to Do Activities I Enjoy Most


name: Emotional Distress - Anxiety Subordinate Domain


name: Emotional Distress - Depressive Symptoms Subordinate Domain


name: Sleep-Related Disturbance Subordinate Domain


name: Physical Function - Mobility Subordinate Domain


name: PROMIS Pediatric and Parent Proxy Mental Health Domain


name: Extent that Dry Mouth Interfered with Usual Activities


name: Extent that Mouth or Throat Pain Interfered with Usual Activities


name: Extent that Change in Taste of Food or Drink Interfered with Eating Usual Food


name: Extent that Nausea Interfered with Usual Activities


name: Extent that Vomiting Interfered with Usual Activities


name: Extent that Constipation Interfered with Usual Activities


name: Extent that Diarrhea Interfered with Usual Activities


name: Extent that Stomach Pain Interfered with Usual Activities


name: Extent that Coughing Interfered with Usual Activities


name: Extent that Itchy Skin Interfered with Usual Activities


name: Extent that Hand or Foot Numbness or Tingling Interfered with Usual Activities


name: Extent that Muscle Pain Interfered with Usual Activities


name: Extent that Joint Pain Interfered with Usual Activities


name: Amivantamab and Recombinant Human Hyaluronidase


name: 4-Dimensional Magnetic Resonance Imaging


name: Medical Product Dispensation- or Prescription-Related Activity


name: Report Treatment Discontinuation or Transfer of Care


name: Establish Processes and Procedures to Notify


name: Establish Processes and Procedures to Provide


name: Do Not Dispense Outside of Specified Facility


name: Patient Must have a Specified Item or Intervention


name: Distribute Only to Certified Healthcare Provider or Setting


name: Have Someone Who Makes Me Feel Appreciated


name: Operational Ontology for Radiation Oncology Terminology


name: Operational Ontology for Radiation Oncology Prostate Cancer Terminology


name: Intensity Modulated Radiation Therapy Leaf Motion


name: Inter-fraction Adaptation of Treatment Plan


name: Intra-fraction Adaptation of Treatment Plan


name: Date of Report at Diagnosis and Staging of Prostate Cancer


name: Multiple Static Segments Radiation Therapy Delivery Method


name: Automated Multi-Institution Validated - Atlas Based Planning Structure Generation


name: Automated Multi-Institution Validated - Algorithm Based Planning Structure Generation


name: Automated Multi-Institution Validated - Artificial Intelligence/Machine Learning Planning Structure Generation


name: Automated Single Institution Validated - Atlas Based Planning Structure Generation


name: Automated Single Institution Validated - Algorithm Based Planning Structure Generation


name: Automated Single Institution Validated - Artificial Intelligence/Machine Learning Planning Structure Generation


name: Automated Commercial Radiotherapy Treatment Planning System


name: Automated In-House Radiotherapy Treatment Planning System


name: Fixed Basis Relative Biological Effectiveness


name: LET-based Relative Biological Effectiveness


name: Variable Biologic Model-based Relative Biological Effectiveness


name: Breath Control Used as Part of Treatment


name: Fiducial Markers Used for Image Guidance


name: Heterogeneity Correction Used in Dose Calculation


name: How Likely is Death Related to Treatment


name: Imaging Captured to Calculate Treatment Session Dose and Compare to Original Plan


name: Intervention Performed Prior to Radiation Therapy


name: Prescription Specifies Dose Objectives For Single Course


name: Prescription Specifies Dose Objectives For Single Phase


name: Prescription Specifies Dose Objectives For Single Treatment Plan


name: Primary ICD Codes When Treating Secondary


name: Quantitative Dose Calculations Performed to Evaluate Cumulative Doses


name: Radiation Field for Current Course Overlaps with Prior Courses


name: Structure Type is Target Structure or Organ at Risk


name: Systemic Therapy Administration Frequency


name: Patient-reported Outcome Question Identifier


name: Duration of Radiation Delivery in Session


name: Duration of Treating Field Radiation in Fraction


name: Duration of Treating Plan Radiation in Fraction


name: Date of Report of Androgen Deprivation Therapy


name: Date of Report of Interventional Procedure


name: Date of Report of Patient Reported Outcome


name: Date of Report of Patient Treatment Outcome


name: Date of Report of Provider Reported Toxicity


name: Date of Report of Radiation Therapy Course


name: Date of Report of Radiation Therapy Course Event


name: Date of Report of Radiation Therapy Course Session


name: Date of Report of Radiation Therapy Prescription


name: Date of Report of Reirradiation Evaluation


name: Date of Report of Systemic Therapy Course


name: Date of Report of Systemic Therapy Cycle


name: Date of Report of Treated Field in Treated Radiation Therapy Plan Fraction


name: Date of Report of Treated Radiation Therapy Plan


name: Uniform Active Scanning Proton Beam Therapy


name: Moderately Hypofractionated Radiation Therapy


name: Tertiary Gleason Pattern at Prostatectomy


name: Secondary Gleason Pattern at Prostatectomy


name: Primary Gleason Pattern at Prostatectomy


name: GPS Coordinates of Intervention Facility


name: Adaptation or Revision of Treatment Plan Name


name: Radiation Oncology Information System Plan Name


name: Fraction of Plan Dose Associated with Field


name: Number of Prescribed Radiation Therapy Sessions


name: Carbon-11 Choline Positron Emission Tomography


name: F-18 Fluciclovine Positron Emission Tomography


name: Hybrid Intracavitary and Interstitial Brachytherapy


name: Standardized Minimal Time Before Time Repair Weighting Factor


name: International Soft Tissue Sarcoma Consortium


name: International Pediatric Acute Myeloid Leukemia Consortium


name: Global Retinoblastoma Alliance for Children


name: Consortium for Childhood Cancer Predisposition


name: Japan Children's Cancer Group Neuroblastoma Committee


name: International Society of Paediatric Oncology Europe Neuroblastoma Group


name: European Paediatric Soft Tissue Sarcoma Study Group


name: European Society for Paediatric Oncology


name: Defining Platforms for Individualized Cancer Treatment


name: CELLOSAURUS Resistance and Transformant Physical Factor Terminology


name: NCCN Prostate Cancer Very Low Risk Group


name: NCCN Prostate Cancer Intermediate Risk Group


name: NCCN Prostate Cancer Favorable-Intermediate Risk Group


name: NCCN Prostate Cancer Unfavorable-Intermediate Risk Group


name: NCCN Prostate Cancer Very High Risk Group


name: Japanese Infantile Neuroblastoma Collaborative Study Group


name: Elixhauser Malignant Solid Tumors in Situ Value Set


name: Elixhauser Malignant Solid Tumors without Metastases Value Set


name: Elixhauser Cerebrovascular Disease Value Set


name: Elixhauser Chronic Pulmonary Disease Value Set


name: Elixhauser Coagulation Deficiency Value Set


name: Elixhauser Congestive Heart Failure Value Set


name: Elixhauser Diabetes with Chronic Complications Value Set


name: Elixhauser Diabetes without Chronic Complications Value Set


name: Elixhauser Hypertension, Complicated Value Set


name: Elixhauser Hypertension, Uncomplicated Value Set


name: Elixhauser Moderate to Severe Liver Disease Value Set


name: Elixhauser Neurological Movement Disorder Value Set


name: Elixhauser Neurological Seizure Disorder Value Set


name: Elixhauser Other Neurological Disorder Value Set


name: Elixhauser Other Thyroid Disorder Value Set


name: Elixhauser Peripheral Vascular Disease Value Set


name: Elixhauser Pulmonary Circulation Disorder Value Set


name: Elixhauser Moderate Renal Failure Value Set


name: Elixhauser Severe Renal Failure Value Set


name: Elixhauser Rheumatoid Arthritis and Collagen Vascular Disease Value Set


name: Elixhauser Chronic Peptic Ulcer Disease Value Set


name: Benign Neoplasm of Brain and CNS Disorder Value Set


name: Body Location and Laterality Qualifier Value Set


name: Brachytherapy High Dose Rate Electronic Technique Value Set


name: Brachytherapy High Dose Rate Technique Value Set


name: Brachytherapy Low Dose Rate Temporary Radation Technique Value Set


name: Brachytherapy Permanent Seeds Technique Value Set


name: Brachytherapy Pulsed Dose Rate Technique Value Set


name: Brachytherapy Radiopharmaceutical Technique Value Set


name: Cytologic Evidence of Malignancy Value Set


name: Staging Type Value Set (for Distant Metastases Category)


name: Staging Type for Primary Tumor Category Value Set


name: Staging Type for Regional Node Category Value Set


name: Primary Malignant Neoplasm Disorder Value Set


name: Radiotherapy Treatment Location Qualifier Value Set


name: Radiotherapy Treatment Location Value Set


name: CDISC Clinical Classification Tanner Scale Girl TANN0101 Original Response Terminology


name: CDISC Clinical Classification Tanner Scale Girl TANN0101 Standardized Character Response Terminology


name: CDISC Clinical Classification Tanner Scale Girl TANN0102 Original Response Terminology


name: CDISC Clinical Classification Tanner Scale Girl TANN0102 Standardized Character Response Terminology


name: CDISC Clinical Classification Tanner Scale Boy TANN0201 Original Response Terminology


name: CDISC Clinical Classification Tanner Scale Boy TANN0201 Standardized Character Response Terminology


name: CDISC Clinical Classification Tanner Scale Boy TANN0202 Original Response Terminology


name: CDISC Clinical Classification Tanner Scale Boy TANN0202 Standardized Character Response Terminology


name: CDISC Questionnaire Kidney Disease and Quality of Life-36 Version 1 Test Name Terminology


name: CDISC Questionnaire Kidney Disease and Quality of Life-36 Version 1 Test Code Terminology


name: CDISC Questionnaire Falls Efficacy Scale Test Name Terminology


name: CDISC Questionnaire Falls Efficacy Scale Test Code Terminology


name: CDISC ADaM National Early Warning Score 2 Clinical Classification Parameter Name Terminology


name: CDISC ADaM National Early Warning Score 2 Clinical Classification Parameter Code Terminology


name: Kidney Disease and Quality of Life-36 Version 1 Questionnaire Question


name: Falls Efficacy Scale Questionnaire Question


name: National Early Warning Score 2 Clinical Classification Question


name: Kidney Disease and Quality of Life-36 Version 1 Questionnaire


name: KDQOL-36 Version 1 - In General You Say Your Health Is


name: KDQOL-36 Version 1 - Limit Moderate Activities


name: KDQOL-36 Version 1 - Limit Climbing Several Flights


name: KDQOL-36 Version 1 - Physical: Accomplished Less


name: KDQOL-36 Version 1 - Physical: Limited Kind of Work


name: KDQOL-36 Version 1 - Emotional: Accomplished Less


name: KDQOL-36 Version 1 - Emotional: Did Work Less Carefully


name: KDQOL-36 Version 1 - Pain Interfere With Normal Work


name: KDQOL-36 Version 1 - Have You Felt Calm and Peaceful


name: KDQOL-36 Version 1 - Did You Have a Lot of Energy


name: KDQOL-36 Version 1 - You Felt Downhearted and Blue


name: KDQOL-36 Version 1 - Time Physical or Emotional Interfered


name: KDQOL-36 Version 1 - Kidney Disease Interferes With Life


name: KDQOL-36 Version 1 - Time Spent Deal With Kidney Disease


name: KDQOL-36 Version 1 - Frustrated Deal With Kidney Disease


name: KDQOL-36 Version 1 - I Feel Like a Burden on My Family


name: KDQOL-36 Version 1 - Bothered by Soreness in Muscles


name: KDQOL-36 Version 1 - Bothered by Chest Pain


name: KDQOL-36 Version 1 - Bothered by Itchy Skin


name: KDQOL-36 Version 1 - Bothered by Dry Skin


name: KDQOL-36 Version 1 - Bothered by Shortness of Breath


name: KDQOL-36 Version 1 - Bothered by Faintness or Dizziness


name: KDQOL-36 Version 1 - Bothered by Lack of Appetite


name: KDQOL-36 Version 1 - Bothered by Washed Out or Drained


name: KDQOL-36 Version 1 - Bothered by Numbness in Hands or Feet


name: KDQOL-36 Version 1 - Bothered by Nausea or Upset Stomach


name: KDQOL-36 Version 1 - Bothered by Problems With Access Site


name: KDQOL-36 Version 1 - Bothered by Problems Catheter Site


name: KDQOL-36 Version 1 - Bother Fluid Restriction


name: KDQOL-36 Version 1 - Bother Dietary Restriction


name: KDQOL-36 Version 1 - Bother Ability to Work Around House


name: KDQOL-36 Version 1 - Bother Your Ability to Travel


name: KDQOL-36 Version 1 - Bother Dependent on Doctors and Staff


name: KDQOL-36 Version 1 - Bother Stress Caused by Disease


name: KDQOL-36 Version 1 - Bother Your Sex Life


name: KDQOL-36 Version 1 - Bother Your Personal Appearance


name: FES - Prepare Meals Not Carrying Objects


name: Prophylactic Removal due to Corrective Action


name: Cancer Antigen 125 [Units/Volume] in Serum or Plasma


name: CD30 Antigen [Presence] in Tissue by Immune Stain


name: CD20 Antigen [Presence] in Tissue by Immune Stain


name: Prostate-Specific Antigen [Presence] in Tissue by Immune Stain


name: Carcinoembryonic Antigen [Units/Volume] in Semen


name: Cancer Antigen 125 [Units/Volume] in Body Fluid


name: Carcinoembryonic Antigen [Mass/Volume] in Body Fluid


name: Cancer Antigen DM/70K [Units/Volume] in Serum or Plasma


name: Choriogonadotropin Beta Subunit [Units/Volume] in Cerebral Spinal Fluid


name: Cells with Estrogen Receptor/100 Cells in Tissue by Immune Stain


name: Cells with Progesterone Receptor/100 Cells in Tissue by Immune Stain


name: CD20 Abnormal Blood Cells/Abnormal Blood Cells Total in Blood


name: CD33 Abnormal Blood Cells/Abnormal Blood Cells Total in Blood


name: Gamma-Enolase [Mass/Volume] in Serum or Plasma


name: Cancer Antigen 125 [Units/Volume] in Body Fluid by Dilution


name: Cancer Antigen 125 [Units/Volume] in Serum or Plasma by Dilution


name: Cancer Antigen 27-29 [Units/Volume] in Serum or Plasma


name: Cancer Antigen 72-4 [Units/Volume] in Serum or Plasma


name: Cancer Antigen 19-9 [Units/Volume] in Pleural Fluid


name: Cancer Antigen 72-4 [Units/Volume] in Pleural Fluid


name: Cancer Antigen 125 [Units/Volume] in Pleural Fluid


name: Carcinoembryonic Antigen [Units/Volume] in Serum or Plasma


name: Carcinoembryonic Antigen [Moles/Volume] in Serum or Plasma


name: Carcinoembryonic Antigen [Units/Volume] in Pleural Fluid


name: Carcinoembryonic Antigen [Mass/Volume] in Pleural Fluid


name: Carcinoembryonic Antigen [Moles/Volume] in Pleural Fluid


name: Choriogonadotropin Beta Subunit [Units/Volume] in Amniotic Fluid


name: Choriogonadotropin Beta Subunit [Moles/Volume] in Amniotic Fluid


name: Cancer Antigen 27-29 [Units/Volume] in Pleural Fluid


name: Cancer Antigen 549 [Units/Volume] in Serum or Plasma


name: Cancer Antigen 549 [Units/Volume] in Pleural Fluid


name: Gamma-Enolase [Units/Volume] in Serum or Plasma


name: Gamma-Enolase [Units/Volume] in Pleural Fluid


name: Prostate-Specific Antigen [Units/Volume] in Serum or Plasma


name: Prostate-Specific Antigen [Moles/Volume] in Serum or Plasma


name: Prostate-Specific Antigen [Units/Volume] in Semen


name: Prostate-Specific Antigen [Mass/Volume] in Semen


name: Prostate-Specific Antigen [Moles/Volume] in Semen


name: Cancer Antigen 125 [Presence] in Serum or Plasma


name: Cancer Antigen 15-3 [Presence] in Serum or Plasma


name: Cancer Antigen 19-9 [Presence] in Serum or Plasma


name: Cancer Antigen 242 [Presence] in Serum or Plasma


name: Cancer Antigen 27-29 [Presence] in Serum or Plasma


name: Cancer Antigen 50 [Presence] in Serum or Plasma


name: Cancer Antigen 549 [Presence] in Serum or Plasma


name: Cancer Antigen 72-4 [Presence] in Serum or Plasma


name: Carcinoembryonic Antigen [Mass/Volume] in Cerebral Spinal Fluid


name: Carcinoembryonic Antigen [Mass/Volume] in Semen


name: Carcinoembryonic Antigen [Mass/Volume] in Serum or Plasma


name: Choriogonadotropin Beta Subunit [Units/Volume] in Serum or Plasma by Enzyme Immunoassay Third International Standard


name: CD20 Cells/100 Cells in Unspecified Specimen


name: CD22 Cells/100 Cells in Unspecified Specimen


name: CD33 Cells/100 Cells in Unspecified Specimen


name: Choriogonadotropin Beta Subunit [Moles/Volume] in Serum or Plasma


name: Choriogonadotropin Beta Subunit [Mass/Time] in 24 Hour Urine


name: Choriogonadotropin Beta Subunit [Moles/Volume] in Urine


name: Choriogonadotropin Beta Subunit [Units/Volume] in Serum or Plasma


name: BRCA1 Gene Variants Found [Identifier] in Blood or Tissue by Molecular Genetics Method Nominal


name: BRCA1 NM_007294.3:c.68_69delAG [Presence] in Blood or Tissue by Molecular Genetics Method


name: BRCA1 NM_007294.3c.5266dupC [Presence] in Blood or Tissue by Molecular Genetics Method


name: BRCA1 Gene Variants Tested for in Blood or Tissue by Molecular Genetics Method Nominal


name: BRCA2 NM_000059.3:c.5946delT [Presence] in Blood or Tissue by Molecular Genetics Method


name: KRAS Gene Variants Found [Identifier] in Blood or Tissue by Molecular Genetics Method Nominal


name: KRAS Gene Variants Tested for in Blood or Tissue by Molecular Genetics Method Nominal


name: Gamma-Enolase [Enzymatic Activity/Volume] in Serum or Plasma


name: Cancer Antigen 19-9 [Units/Volume] in Serum or Plasma


name: Cancer Antigen 19-9 [Units/Volume] in Body Fluid


name: Bladder Tumor Antigen [Presence] in Urine by Immunoassay


name: Bladder Tumor Antigen [Units/Volume] in Urine by Immunoassay


name: Prostate-Specific Antigen [Mass/Volume] in Serum or Plasma


name: Cancer Antigen 15-3 [Units/Volume] in Body Fluid


name: Choriogonadotropin Beta Subunit [Units/Volume] in Body Fluid


name: CD25 Antigen [Presence] in Tissue by Immune Stain


name: Nuclear Mitotic Apparatus Protein 1 [Units/Volume] in Urine


name: Bladder Tumor Antigen [Presence] in Urine


name: Bladder Tumor Antigen [Units/Volume] in Urine


name: Epidermal Growth Factor Receptor [Presence] in Tissue by Immune Stain


name: Receptor Tyrosine-Protein Kinase erbB-2 [Mass/Volume] in Serum


name: Cancer Antigen 72-4 [Units/Volume] in Body Fluid


name: Cancer Antigen 50 [Units/Volume] in Serum or Plasma


name: Des-Gamma Carboxyprothrombin [Mass/Volume] in Serum or Plasma


name: Prostate-Specific Antigen [Mass/Volume] in Urine


name: Prostate-Specific Antigen [Mass/Volume] in Serum or Plasma by Detection Limit Less than or Equal to 0.01 ng/ml


name: BRCA2 Gene Variants Found [Identifier] in Blood or Tissue by Molecular Genetics Method Nominal


name: BRCA2 Gene Variants Tested for in Blood or Tissue by Molecular Genetics Method Nominal


name: Epidermal Growth Factor Receptor [Presence] in Tissue


name: Mast/Stem Cell Growth Factor Receptor Kit [Presence] in Tissue by Immune Stain


name: Estrogen Receptor [Presence] in Tissue by Immune Stain


name: Progesterone Receptor [Presence] in Tissue by Immune Stain


name: Cancer Antigen 125 [Units/Volume] in Peritoneal Fluid


name: Carcinoembryonic Antigen [Mass/Volume] in Pericardial Fluid


name: Carcinoembryonic Antigen [Mass/Volume] in Peritoneal Fluid


name: Soluble Mesothelin Related Protein [Moles/Volume] in Serum or Plasma


name: Phosphorylated Epidermal Growth Factor Receptor [Presence] in Tissue by Immune Stain


name: Receptor Tyrosine-Protein Kinase erbB-2 [Mass/Volume] in Serum by Immunoassay


name: JAK2 NP_004963.1:p.V617F [Presence] in Blood or Tissue by Molecular Genetics Method


name: Choriogonadotropin Beta Subunit [Presence] in Specimen


name: Choriogonadotropin Beta Subunit [Presence] in Cerebral Spinal Fluid


name: Gamma-Enolase [Mass/Volume] in Cerebral Spinal Fluid


name: DPYD Gene Variants Found [Identifier] in Blood or Tissue by Molecular Genetics Method Nominal


name: Cancer Antigen 72-4 [Presence] in Tissue by Immune Stain


name: Gamma-Enolase [Mass/Volume] in Cerebral Spinal Fluid by Immunoassay


name: Prostate-Specific Antigen [Mass/Volume] in Body Fluid


name: Gamma-Enolase [Mass/Volume] in Serum or Plasma by Radioimmunoassay


name: Gamma-Enolase [Mass/Volume] in Body Fluid


name: Receptor Tyrosine-Protein Kinase erbB-2 [Interpretation] in Tissue


name: Cancer Antigen 125 [Presence] in Tissue by Immune Stain


name: X and Y Chromosome [Interpretation] in Blood or Marrow by FISH-Post Bone Marrow Transplant


name: X-Linked Heterotaxy [Identifier] in Blood or Tissue by FISH Narrative


name: FGFR2 Gene and FGFR3 Gene Variants Found [Identifier] in Blood or Tissue by Molecular Genetics Method Nominal


name: BCR/ABL1 b2a2 Type Fusion Protein [Presence] in Blood or Tissue by Molecular Genetics Method


name: Chromosome Analysis Interphase [Interpretation] in Bone Marrow by FISH Narrative


name: Nuclear Mitotic Apparatus Protein 1 [Presence] in Urine


name: Chromosome Analysis Interphase [Interpretation] in Blood by FISH Narrative


name: Cancer Antigen 125 [Units/Volume] in Cerebral Spinal Fluid


name: Cancer Antigen 15-3 [Units/Volume] in Cerebral Spinal Fluid


name: Cancer Antigen 15-3 [Units/Volume] in Pericardial Fluid


name: Cancer Antigen 15-3 [Units/Volume] in Peritoneal Fluid


name: Cancer Antigen 19-9 [Units/Volume] in Cerebral Spinal Fluid


name: Cancer Antigen 19-9 [Units/Volume] in Pericardial Fluid


name: Cancer Antigen 19-9 [Units/Volume] in Peritoneal Fluid


name: Cancer Antigen 27-29 [Units/Volume] in Cerebral Spinal Fluid


name: CD20 Blasts/100 Blasts in Unspecified Specimen


name: CD22 Blasts/100 Blasts in Unspecified Specimen


name: CD22 Blasts [Units/Volume] in Unspecified Specimen


name: CD33 Blasts/100 Blasts in Unspecified Specimen


name: CD33 Blasts [Units/Volume] in Unspecified Specimen


name: Mast/Stem Cell Growth Factor Receptor Kit [Presence] in Bone Marrow by Immune Stain


name: Mast/Stem Cell Growth Factor Receptor Kit [Presence] in Blood by Immune Stain


name: Mast/Stem Cell Growth Factor Receptor Kit [Presence] in Unspecified Specimen by Immune Stain


name: t(9;22)(q34.1;q11)(ABL1/BCR) Fusion Transcript in Blood or Tissue by FISH


name: Receptor Tyrosine-Protein Kinase erbB-2 [Presence] in Serum by Immunoassay


name: KRAS Gene Variants Found [Identifier] in Bone Marrow by Molecular Genetics Method Nominal


name: WAP Four-Disulfide Core Domain Protein 2 [Moles/Volume] in Serum or Plasma


name: Chromosome Analysis Interphase [Interpretation] in Amniotic Fluid by FISH Narrative


name: Chromosome Analysis Interphase [Interpretation] in Chorionic Villus Sample by FISH Narrative


name: Choriogonadotropin Beta Subunit [Multiple of the Median] in Serum or Plasma


name: Choriogonadotropin Beta Subunit [Mass/Volume] in Serum or Plasma


name: Choriogonadotropin Beta Subunit [Units] in 24 Hour Urine


name: Beta-2-Microglobulin Tumor Marker [Mass/Volume] in Serum


name: Chromosome 13 and 18 and 21 and X and Y Aneuploidy in Amniotic Fluid or Chorionic Villus Sample by FISH Nominal


name: Chromosome 13 and 18 and 21 and X and Y Aneuploidy in Blood or Tissue by FISH Nominal


name: Gamma-Enolase [Mass/Volume] in Serum or Plasma by Immunoassay


name: Chromosome Analysis Interphase [Interpretation] in Blood or Marrow by FISH Narrative


name: Cancer Antigen 125 [Units/Volume] in Peritoneal Dialysis Fluid


name: Chromosome Analysis Interphase [Interpretation] in Specimen by FISH Narrative


name: Prostate-Specific Antigen [Mass/Volume] in Pleural Fluid


name: Prostate-Specific Antigen [Mass/Volume] in Peritoneal Fluid


name: Prostate-Specific Antigen [Mass/Volume] in Cerebral Spinal Fluid


name: t(15;17)(q24.1;q21.1)(PML/RARA) BCR2 Type Fusion Transcript [Presence] in Blood or Tissue by Molecular Genetics Method


name: T-Cell Receptor Excision Circle [Number/Volume] in Dried Blood Spot by Nucleic Acid Amplification with Probe Detection


name: Chromosome Analysis Metaphase Panel - Blood by FISH


name: Chromosome Analysis Interphase Panel - Blood by FISH


name: Chromosome Analysis Interphase Panel - Amniotic Fluid by FISH


name: Chromosome Analysis Prenatal Panel by FISH


name: Chromosome Analysis Metaphase Panel - Amniotic Fluid by FISH


name: TOP2A Gene 17q21-22 Deletion and Duplication Analysis [Presence] in Tissue by FISH


name: Choriogonadotropin Beta Subunit [Units/Volume] in Pleural Fluid


name: Choriogonadotropin Beta Subunit [Units/Volume] in Peritoneal Fluid


name: Cancer Antigen 15-3 [Units/Volume] in Serum or Plasma


name: Cancer Antigen 125 [Units/Volume] in Pericardial Fluid


name: Cancer Antigen 72-4 [Units/Volume] in Peritoneal Fluid


name: Cancer Antigen 72-4 [Units/Volume] in Cerebral Spinal Fluid


name: Cancer Antigen 72-4 [Units/Volume] in Pericardial Fluid


name: Gamma-Enolase [Mass/Volume] in Pleural Fluid


name: Gamma-Enolase [Mass/Volume] in Pericardial Fluid


name: Gamma-Enolase [Mass/Volume] in Peritoneal Fluid


name: t(15;17)(q24.1;q21.1)(PML/RARA) BCR2 Type Fusion Transcript/Control Transcript [Number Ratio] in Bone Marrow by Molecular Genetics Method


name: t(15;17)(q24.1;q21.1)(PML/RARA) BCR2 Type Fusion Transcript/Control Transcript [Number Ratio] in Blood or Tissue by Molecular Genetics Method


name: JAK2 NP_004963.1:p.V617F [Presence] in Bone Marrow by Molecular Genetics Method


name: Receptor Tyrosine-Protein Kinase erbB-2 [Units/Volume] in Tissue by Immunoassay


name: Receptor Tyrosine-Protein Kinase erbB-2 [Presence] in Tissue by Immunoassay


name: UGT1A1*28 [Presence] in Blood or Tissue by Molecular Genetics Method


name: FLT3 NP_004110.2:p.D835X and NP_004110.2:p.I836X Variants [Presence] in Blood or Tissue by Molecular Genetics Method


name: Subtelomere Analysis Long Arm [Interpretation] in Blood or Tissue by FISH Narrative


name: Subtelomere Analysis Short Arm [Interpretation] in Blood or Tissue by FISH Narrative


name: SNRPN Gene 15q11 Deletion and Duplication Analysis [Identifier] in Blood or Tissue by FISH Nominal


name: t(11;14)(q13.2;q32)(MYEOV/IGH) Fusion Transcript [Identifier] in Blood or Tissue by FISH Nominal


name: t(4;14)(p16;q32)(FGFR3/IGH) Fusion Transcript [Identifier] in Blood or Tissue by FISH Nominal


name: del(13q14) [Identifier] in Blood or Tissue by FISH Nominal


name: del(17p13) [Identifier] in Blood or Tissue by FISH Nominal


name: dic(9;20)(p11-13;q11)(der9 and der20 Positive by Whole Chromosome Paint) [Identifier] in Blood or Tissue by FISH Nominal


name: Staphylococcus aureus and Staphylococcus sp. Coagulase Negative rRNA [Identifier] by FISH in Positive Blood Culture


name: RAI1 Gene 17p11.2 Deletion and Duplication Analysis [Identifier] in Blood or Tissue by FISH Nominal


name: ERBB2 Gene Duplication Associated Observations Panel - Tissue by FISH


name: KRAS Gene Targeted Variant Analysis in Blood or Tissue by Molecular Genetics Method


name: t(1;19)(q23.3;p13.3)(PBX1/TCF3) Fusion Transcript in Blood or Tissue by FISH


name: t(15;17)(q24.1;q21.1)(PML/RARA) Fusion Transcript in Blood or Tissue by FISH


name: t(8;14)(q24;q32)(MYC/IGH) Fusion Transcript in Blood or Tissue by FISH


name: t(14;16)(q32;q23)(IGH/MAF) Fusion Transcript in Blood or Tissue by FISH


name: inv(16)(p13.1;q22.1)(MYH11/CBFB) Fusion Transcript in Blood or Tissue by FISH


name: t(14;18)(q32;q21)(IGH/MALT1) Fusion Transcript in Blood or Tissue by FISH


name: t(11;18)(q21;q21)(BIRC3/MALT1) Fusion Transcript in Blood or Tissue by FISH


name: t(11;14)(q13;q32)(CCND1/IGH) Fusion Transcript in Blood or Tissue by FISH


name: t(14;18)(q32;q21.3)(IGH/BCL2) Fusion Transcript in Blood or Tissue by FISH


name: t(12;21)(p13;q22.3)(ETV6/RUNX1) Fusion Transcript in Blood or Tissue by FISH


name: t(8;21)(q22;q22.3)(RUNX1T1/RUNX1) Fusion Transcript in Blood or Tissue by FISH


name: inv(3)(q21;q26.2) and t(3;3)(q21;q26.2) Fusion Transcript in Blood or Tissue by FISH


name: t(6;9)(p22;q34)(DEK/NUP214) Fusion Transcript in Blood or Tissue by FISH


name: Cells with 4q12 Chromosome Region Rearrangements/Cells Counted in Blood or Tissue by FISH


name: Cells with 9q34 Chromosome Region Deletion/Cells Counted in Blood or Tissue by FISH


name: Cells with BCL6 Gene Rearrangements/Cells Counted in Blood or Tissue by FISH


name: Cells with CCND1 Gene Duplication/Cells Counted in Blood or Tissue by FISH


name: TRA and TRD Gene Rearrangements [Presence] in Blood or Tissue by FISH


name: KMT2A Gene Rearrangements [Presence] in Blood or Tissue by FISH


name: TRA and TRD Gene Rearrangements [Interpretation] in Blood or Tissue by FISH Narrative


name: KMT2A Gene Rearrangements [Interpretation] in Blood or Tissue by FISH Narrative


name: Cells with MYC Gene Rearrangements/Cells Counted in Blood or Tissue by FISH


name: Cells with RARA Gene Rearrangements/Cells Counted in Blood or Tissue by FISH


name: Cells with TRA and TRD Gene Rearrangements/Cells Counted in Blood or Tissue by FISH


name: Cells with BCL2 Gene Rearrangements/Cells Counted in Blood or Tissue by FISH


name: Cells with ALK Gene Rearrangements/Cells Counted in Blood or Tissue by FISH


name: Cells with KMT2A Gene Rearrangements/Cells Counted in Blood or Tissue by FISH


name: Cells with PDGFRB Gene Rearrangements/Cells Counted in Blood or Tissue by FISH


name: Cells with IGH Gene Rearrangements/Cells Counted in Blood or Tissue by FISH


name: Cells with MYB Gene Deletion/Cells Counted in Blood or Tissue by FISH


name: Cells with FGFR1 Gene Rearrangements/Cells Counted in Blood or Tissue by FISH


name: inv(2)(p21;p23)(EML4/ALK) Fusion Transcript [Presence] in Blood or Tissue by FISH


name: BRCA1 Gene Variant Analysis Limited To Known Familial Variants in Blood or Tissue by Molecular Genetics Method


name: BRCA2 Gene Variant Analysis Limited To Known Familial Variants in Blood or Tissue by Molecular Genetics Method


name: Bladder Tumor Antigen [Presence] in Urine by Rapid Immunoassay


name: CD27 Positive/IgD Negative Cells Per 100 CD19 Positive/CD20 Positive Cells in Blood


name: KRAS and NRAS Gene Variants Found [Identifier] in Blood or Tissue by Molecular Genetics Method Nominal


name: Chromosome Region Yp11.3 Deletion and/or Rearrangement in Blood or Tissue by FISH


name: Chromosome Region 15q11-13 Deletion and Duplication Analysis in Amniotic Fluid or Chorionic Villus Sample by FISH


name: Chromosome Region 22q11.2 Deletion and Duplication Analysis in Amniotic Fluid or Chorionic Villus Sample by FISH


name: Chromosome Region 22q11.2 Deletion and Duplication Analysis in Blood or Tissue by FISH


name: Chromosome Region Xp22.33 and/or Yp11.32 Deletion and Duplication Analysis in Blood or Tissue by FISH


name: KRAS Gene [Variant Call File] in Cancer Specimen by Sequencing


name: Cancer Antigen 125 [Units/Volume] in Serum or Plasma by Immunoassay


name: Cancer Antigen 15-3 [Units/Volume] in Serum or Plasma by Immunoassay


name: Cancer Antigen 19-9 [Units/Volume] in Serum or Plasma by Immunoassay


name: Carcinoembryonic Antigen [Mass/Volume] in Serum or Plasma by Immunoassay


name: Prostate-Specific Antigen [Mass/Volume] in Serum or Plasma by Immunoassay


name: Cells with Chromosome Region 5q31 Deletion/Cells Counted in Bone Marrow by FISH


name: Cells with Chromosome 12 Trisomy/Cells Counted in Blood or Tissue by FISH


name: Cells with Chromosome Region 13q14 Deletion/Cells Counted in Blood or Tissue by FISH


name: Cells with Chromosome Region 11q22.3 Deletion/Cells Counted in Blood or Tissue by FISH


name: Cells with Chromosome Region 17p13.1 Deletion/Cells Counted in Blood or Tissue by FISH


name: Cells with Chromosome Region 5q31 Deletion/Cells Counted in Blood or Tissue by FISH


name: Cells with Chromosome Region 7q31 Deletion/Cells Counted in Blood or Tissue by FISH


name: Cells with Chromosome 7 Monosomy/Cells Counted in Blood or Tissue by FISH


name: BRAF NP_004324.2:p.V600E Protein Variant [Presence] in Cancer Specimen by Immune Stain


name: Receptor Tyrosine-Protein Kinase erbB-2 [Presence] in Breast Cancer Specimen by Immune Stain


name: Cells with Progesterone Receptor/100 Cells in Breast Cancer Specimen by Immune Stain


name: Cells with Estrogen Receptor/100 Cells in Breast Cancer Specimen by Immune Stain


name: Estrogen Receptor [Presence] in Breast Cancer Specimen by Immune Stain


name: Progesterone Receptor [Presence] in Breast Cancer Specimen by Immune Stain


name: KRAS Gene Variants Found [Identifier] in Colorectal Cancer Specimen by Molecular Genetics Method Nominal


name: Cells with Chromosome 3 Monosomy/Cells Counted in Cancer Specimen by FISH


name: Beta-2-Microglobulin [Mass/Volume] in Serum or Plasma - Post Dialysis


name: t(14;20)(q32;q12)(IGH/MAFB) Fusion Transcript in Blood or Tissue by FISH


name: Thiopurine S-Methyltransferase Activity in Red Blood Cells by Production of 6-Methylmercaptopurine


name: Thiopurine S-Methyltransferase Activity in Red Blood Cells by Production of 6-Methylmercaptopurine Riboside


name: Thiopurine S-Methyltransferase Activity in Red Blood Cells by Production of 6-Methylthioguanine Riboside


name: T-Cell Receptor Excision Circle [Cycle Threshold Number] in Dried Blood Spot


name: T-Cell Receptor Excision Circle [Z-Score] in Dried Blood Spot


name: T-Cell Receptor Excision Circle [Multiple of the Median] in Dried Blood Spot


name: FLT3 Gene NP_004110.2:p.D835X Variants [Presence] in Blood or Tissue by Molecular Genetics Method


name: Des-Gamma Carboxyprothrombin [Units/Volume] in Serum or Plasma


name: 1p/1q Chromosome Deletion [Number Ratio] in Tissue by FISH


name: 19q/19p Chromosome Deletion [Number Ratio] in Tissue by FISH


name: Chromosome 13 and 15 and 16 and 18 and 21 and 22 and X and Y Aneuploidy in Products of Conception by FISH


name: ETV6 Gene Rearrangements in Blood or Bone Marrow by FISH


name: WAP Four-Disulfide Core Domain Protein 2 [Mass/Volume] in Serum or Plasma


name: Cancer Antigen 125 [Units/Volume] in Aspirate


name: Cancer Antigen 15-3 [Units/Volume] in Aspirate


name: Cancer Antigen 19-9 [Units/Volume] in Aspirate


name: Toronto Childhood Cancer Stage Guidelines


name: CDISC SEND Toxicokinetic Description Response Terminology


name: CDISC SEND Pregnancy Status Response Terminology


name: CDISC SEND Pregnancy Outcome Response Terminology


name: CDISC SEND Developmental Milestone Test Name Terminology


name: CDISC SEND Developmental Milestone Test Code Terminology


name: CDISC Protocol Substudy Attribute Terminology


name: Antithymocyte Globulin Equine/Cyclosporine Regimen


name: Children's Oncology Group (COG)/National Wilms Tumor Study Group (NWTSG) Stage


name: International Society of Pediatric Oncology (SIOP) Stage


name: Childhood Cancer Stage by Toronto Guidelines v2


name: Childhood Acute Lymphoblastic Leukemia by Toronto Guidelines v2


name: Childhood Acute Lymphoblastic Leukemia Toronto Guidelines v2, Tier 1


name: Childhood Acute Lymphoblastic Leukemia CNS-Negative Toronto Guidelines v2


name: Childhood Acute Lymphoblastic Leukemia CNS-Positive Toronto Guidelines v2


name: Childhood Acute Lymphoblastic Leukemia Toronto Guidelines v2, Tier 2


name: Childhood Acute Lymphoblastic Leukemia CNS 1 Toronto Guidelines v2


name: Childhood Acute Lymphoblastic Leukemia CNS 2 Toronto Guidelines v2


name: Childhood Acute Lymphoblastic Leukemia CNS 3 Toronto Guidelines v2


name: Childhood Hodgkin Lymphoma by Toronto Guidelines v2 Stage


name: Stage I Childhood Hodgkin Lymphoma by Toronto Guidelines v2


name: Stage IA Childhood Hodgkin Lymphoma by Toronto Guidelines v2


name: Stage IB Childhood Hodgkin Lymphoma by Toronto Guidelines v2


name: Stage II Childhood Hodgkin Lymphoma by Toronto Guidelines v2


name: Stage IIA Childhood Hodgkin Lymphoma by Toronto Guidelines v2


name: Stage IIB Childhood Hodgkin Lymphoma by Toronto Guidelines v2


name: Stage III Childhood Hodgkin Lymphoma by Toronto Guidelines v2


name: Stage IIIA Childhood Hodgkin Lymphoma by Toronto Guidelines v2


name: Stage IIIB Childhood Hodgkin Lymphoma by Toronto Guidelines v2


name: Stage IV Childhood Hodgkin Lymphoma by Toronto Guidelines v2


name: Stage IVA Childhood Hodgkin Lymphoma by Toronto Guidelines v2


name: Stage IVB Childhood Hodgkin Lymphoma by Toronto Guidelines v2


name: Childhood Non-Hodgkin Lymphoma by Toronto Guidelines v2 Stage


name: Childhood Non-Hodgkin Lymphoma by Toronto Guidelines v2 Stage, Tier 1


name: Limited Stage Childhood Non-Hodgkin Lymphoma by Toronto Guidelines v2


name: Advanced Stage Childhood Non-Hodgkin Lymphoma by Toronto Guidelines v2


name: Childhood Non-Hodgkin Lymphoma by Toronto Guidelines v2 Stage, Tier 2


name: Stage I Childhood Non-Hodgkin Lymphoma by Toronto Guidelines v2


name: Stage II Childhood Non-Hodgkin Lymphoma by Toronto Guidelines v2


name: Stage III Childhood Non-Hodgkin Lymphoma by Toronto Guidelines v2


name: Stage IV Childhood Non-Hodgkin Lymphoma by Toronto Guidelines v2


name: Childhood Neuroblastoma by Toronto Guidelines v2 Stage


name: Childhood Neuroblastoma by Toronto Guidelines v2 Stage, Tier 1


name: Localized Childhood Neuroblastoma by Toronto Guidelines v2


name: Locoregional Childhood Neuroblastoma by Toronto Guidelines v2


name: Metastatic Childhood Neuroblastoma by Toronto Guidelines v2


name: MS Childhood Neuroblastoma by Toronto Guidelines v2


name: Childhood Neuroblastoma by Toronto Guidelines v2 Stage, Tier 2


name: Stage L1 Childhood Neuroblastoma by Toronto Guidelines v2


name: Stage L2 Childhood Neuroblastoma by Toronto Guidelines v2


name: Stage M Childhood Neuroblastoma by Toronto Guidelines v2


name: Stage MS Childhood Neuroblastoma by Toronto Guidelines v2


name: Childhood Malignant Kidney Neoplasm Excluding Renal Cell Carcinoma by Toronto Guidelines v2 Stage, International Society of Pediatric Oncology (SIOP) Protocol


name: Childhood Malignant Kidney Neoplasm Excluding Renal Cell Carcinoma by Toronto Guidelines v2 Stage, Tier 1, International Society of Pediatric Oncology (SIOP) Protocol


name: Localized Childhood Malignant Kidney Neoplasm Excluding Renal Cell Carcinoma by Toronto Guidelines v2, International Society of Pediatric Oncology (SIOP) Protocol


name: Metastatic Childhood Malignant Kidney Neoplasm Excluding Renal Cell Carcinoma by Toronto Guidelines v2, International Society of Pediatric Oncology (SIOP) Protocol


name: Childhood Malignant Kidney Neoplasm Excluding Renal Cell Carcinoma by Toronto Guidelines v2 Stage, Tier 2, International Society of Pediatric Oncology (SIOP) Protocol


name: Stage y-I Childhood Malignant Kidney Neoplasm Excluding Renal Cell Carcinoma by Toronto Guidelines v2, International Society of Pediatric Oncology (SIOP) Protocol


name: Stage y-II Childhood Malignant Kidney Neoplasm Excluding Renal Cell Carcinoma by Toronto Guidelines v2, International Society of Pediatric Oncology (SIOP) Protocol


name: Stage y-III Childhood Malignant Kidney Neoplasm Excluding Renal Cell Carcinoma by Toronto Guidelines v2, International Society of Pediatric Oncology (SIOP) Protocol


name: Stage IV Childhood Malignant Kidney Neoplasm Excluding Renal Cell Carcinoma by Toronto Guidelines v2, International Society of Pediatric Oncology (SIOP) Protocol


name: Childhood Malignant Kidney Neoplasm Excluding Renal Cell Carcinoma by Toronto Guidelines v2 Stage, Children's Oncology Group (COG) Protocol


name: Childhood Malignant Kidney Neoplasm Excluding Renal Cell Carcinoma by Toronto Guidelines v2 Stage, Tier 1, Children's Oncology Group (COG) Protocol


name: Localized Childhood Malignant Kidney Neoplasm Excluding Renal Cell Carcinoma by Toronto Guidelines v2, Children's Oncology Group (COG) Protocol


name: Metastatic Childhood Malignant Kidney Neoplasm Excluding Renal Cell Carcinoma by Toronto Guidelines v2, Children's Oncology Group (COG) Protocol


name: Childhood Malignant Kidney Neoplasm Excluding Renal Cell Carcinoma by Toronto Guidelines v2 Stage, Tier 2, Children's Oncology Group (COG) Protocol


name: Number of Days Between Index Date and First Event


name: Number of Days Between Index Date and Risk Factor Diagnosis


name: Stage I Childhood Malignant Kidney Neoplasm Excluding Renal Cell Carcinoma by Toronto Guidelines v2, Children's Oncology Group (COG) Protocol


name: Stage II Childhood Malignant Kidney Neoplasm Excluding Renal Cell Carcinoma by Toronto Guidelines v2, Children's Oncology Group (COG) Protocol


name: Stage III Childhood Malignant Kidney Neoplasm Excluding Renal Cell Carcinoma by Toronto Guidelines v2, Children's Oncology Group (COG) Protocol


name: Stage IV Childhood Malignant Kidney Neoplasm Excluding Renal Cell Carcinoma by Toronto Guidelines v2, Children's Oncology Group (COG) Protocol


name: Childhood Malignant Kidney Neoplasm Excluding Renal Cell Carcinoma by Toronto Guidelines v2 Stage


name: Paid for Accommodations When Travelling to Health Center or Consultations


name: Paid for Additional Non-Medical Services


name: Incurred Other Expenses Related to Accessing Health Care Services


name: Incurred Expenses for Purchase of Medical Devices


name: Incurred Expenses for Home Care Services


name: Did Someone Accompany You to Health Center or Consultations


name: Travelled Together with a Caregiver or Companion to Health Center


name: Caregiver or Companion Incurred Other Expenses


name: How Long Was Waiting Time Experienced by Caregiver or Companion During Medical Consultations


name: How Much Total Travel Time for Caregiver or Companion for Non-Medical Consultations


name: How Long Was Waiting Time for Caregiver or Companion for Non-Medical Consultations


name: Average Time per Week Caregiver or Companion Spends Performing Tasks


name: Total Number of Radiotherapy Dose Fractions Received


name: Peritoneal Wash Cytology Results Indicator


name: Childhood Rhabdomyosarcoma by Toronto Guidelines v2 Stage


name: Childhood Rhabdomyosarcoma by Toronto Guidelines v2 Stage, Tier 1


name: Localized Childhood Rhabdomyosarcoma by Toronto Guidelines v2


name: Metastatic Childhood Rhabdomyosarcoma by Toronto Guidelines v2


name: Childhood Rhabdomyosarcoma by Toronto Guidelines v2 Stage, Tier 2


name: Stage I Childhood Rhabdomyosarcoma by Toronto Guidelines v2


name: Stage II Childhood Rhabdomyosarcoma by Toronto Guidelines v2


name: Stage III Childhood Rhabdomyosarcoma by Toronto Guidelines v2


name: Stage IV Childhood Rhabdomyosarcoma by Toronto Guidelines v2


name: Childhood Non-Rhabdomyosarcoma Soft Tissue Sarcoma by Toronto Guidelines v2 Stage


name: Childhood Non-Rhabdomyosarcoma Soft Tissue Sarcoma by Toronto Guidelines v2 Stage, Tier 1


name: Localized Childhood Non-Rhabdomyosarcoma Soft Tissue Sarcoma by Toronto Guidelines v2


name: Metastatic Childhood Non-Rhabdomyosarcoma Soft Tissue Sarcoma by Toronto Guidelines v2


name: Childhood Non-Rhabdomyosarcoma Soft Tissue Sarcoma by Toronto Guidelines v2 Stage, Tier 2


name: Stage I Childhood Non-Rhabdomyosarcoma Soft Tissue Sarcoma by Toronto Guidelines v2


name: Stage II Childhood Non-Rhabdomyosarcoma Soft Tissue Sarcoma by Toronto Guidelines v2


name: Stage III Childhood Non-Rhabdomyosarcoma Soft Tissue Sarcoma by Toronto Guidelines v2


name: Stage IV Childhood Non-Rhabdomyosarcoma Soft Tissue Sarcoma by Toronto Guidelines v2


name: Childhood Malignant Bone Neoplasm by Toronto Guidelines v2 Stage


name: Localized Childhood Malignant Bone Neoplasm by Toronto Guidelines v2


name: Metastatic Childhood Malignant Bone Neoplasm by Toronto Guidelines v2


name: Childhood Retinoblastoma by Toronto Guidelines v2 Stage


name: Childhood Retinoblastoma by Toronto Guidelines v2 Stage, Tier 1


name: Localized Childhood Retinoblastoma by Toronto Guidelines v2


name: Regional Childhood Retinoblastoma by Toronto Guidelines v2


name: Metastatic Childhood Retinoblastoma by Toronto Guidelines v2


name: Childhood Retinoblastoma by Toronto Guidelines v2 Stage, Tier 2


name: Stage 0 Childhood Retinoblastoma by Toronto Guidelines v2


name: Stage I Childhood Retinoblastoma by Toronto Guidelines v2


name: Stage II Childhood Retinoblastoma by Toronto Guidelines v2


name: Stage III Childhood Retinoblastoma by Toronto Guidelines v2


name: Stage IV Childhood Retinoblastoma by Toronto Guidelines v2


name: Childhood Hepatoblastoma by Toronto Guidelines v2 Stage


name: Childhood Hepatoblastoma by Toronto Guidelines v2 Stage, Tier 1


name: Localized Childhood Hepatoblastoma by Toronto Guidelines v2, Tier1


name: Metastatic Childhood Hepatoblastoma by Toronto Guidelines v2, Tier 1


name: Childhood Hepatoblastoma by Toronto Guidelines v2 Stage, Tier 2


name: Localized Childhood Hepatoblastoma by Toronto Guidelines v2, Tier 2


name: Metastatic Childhood Hepatoblastoma by Toronto Guidelines v2, Tier 2


name: Number of Disease-Involved Anatomic Sites


name: Therapeutic Agent Level Achieved Indicator


name: Therapeutic Agent Targeted Administration Concentration


name: Number of Elapsed Days Between Treatment and Outcome


name: Day Times Nanogram Per Milliliter Per Milligram Per Kilogram


name: Distribution Pattern Finding Description


name: Kappa Positive Plasma Cell to Lambda Positive Plasma Cell Ratio Measurement


name: Abnormal Blast to Total Cell Ratio Measurement


name: Abnormal Kappa Positive Plasma Cell Count


name: Abnormal Kappa Positive Plasma Cell to Abnormal Lambda Positive Plasma Cell Ratio Measurement


name: Abnormal Lambda Positive Plasma Cell Count


name: CD25 Cell Surface Expression Measurement


name: CD69 Cell Surface Expression Measurement


name: Clonal Plasma Cell to Total Cell Ratio Measurement


name: Double-Negative Myeloid Dendritic Cell Count


name: Double-Negative Myeloid Dendritic Cell to Myeloid Dendritic Cell Ratio Measurement


name: Intermediate Monocyte to Monocyte Ratio Measurement


name: Non-Classical Monocyte to Monocyte Ratio Measurement


name: Neoplastic Plasma Cell to Total Cell Ratio Measurement


name: Regulatory Helper T-Lymphocyte to Helper T-Lymphocyte Ratio Measurement


name: Stem Cell Memory Helper T-Lymphocyte Count


name: Stem Cell Memory Helper T-Lymphocyte Subpopulation Count


name: Stem Cell Memory Helper T-Lymphocyte Subpopulation to Stem Cell Memory Helper T-Lymphocyte Ratio Measurement


name: Stem Cell Memory Helper T-Lymphocyte to Helper T-Lymphocyte Ratio Measurement


name: Terminal Memory Helper T-Lymphocyte Subpopulation to Terminal Memory Helper T-Lymphocyte Ratio Measurement


name: Terminal Memory Helper T-Lymphocyte Subpopulation to Helper T-Lymphocyte Ratio Measurement


name: Terminal Memory Helper T-Lymphocyte to Helper T-Lymphocyte Ratio Measurement


name: Glycogen Phosphorylase Isoenzyme BB Measurement


name: Lectin-Like Oxidized LDL Receptor-1 Measurement


name: Tumor Necrosis Factor Receptor Superfamily Member 10c Measurement


name: Human Coronavirus 229E Nucleic Acid Measurement


name: Chlamydia pneumoniae Nucleic Acid Measurement


name: Escherichia coli O157 Antigen Measurement


name: Human Bocavirus Nucleic Acid Measurement


name: Human Coronavirus HKU1 Nucleic Acid Measurement


name: Human Metapneumovirus Nucleic Acid Measurement


name: Haemophilus parahaemolyticus DNA Measurement


name: Human Parainfluenza Virus 1 Nucleic Acid Measurement


name: Human Parainfluenza Virus 2 Nucleic Acid Measurement


name: Human Parainfluenza Virus 3 Nucleic Acid Measurement


name: Human Parainfluenza Virus 4B Nucleic Acid Measurement


name: Human Parainfluenza Virus 4 Nucleic Acid Measurement


name: Mycoplasma pneumoniae Nucleic Acid Measurement


name: Human Coronavirus NL63 Nucleic Acid Measurement


name: Neisseria meningitidis A Antigen Measurement


name: Neisseria meningitidis C Antigen Measurement


name: Human Coronavirus OC43 Nucleic Acid Measurement


name: Human Respiratory Syncytial Virus Type A Nucleic Acid Measurement


name: Human Respiratory Syncytial Virus Type B Nucleic Acid Measurement


name: Cell-based Transduction Inhibition Assay


name: Conditioned Orientation Reflex Audiometry


name: High-Performance Liquid Chromatography with Electrochemical Detection


name: Number of First Degree Biological Relatives


name: Ten Billion International Units per Milliliter


name: Ten Billion Viral Particles per Milliliter


name: Thousand International Units per Milliliter


name: Ten Thousand International Units per Milliliter


name: Ten Million International Units per Milliliter


name: One Hundred Million Copies per Milliliter


name: One Hundred Million International Units per Milliliter


name: Billion International Units per Milliliter


name: SEND Developmental and Reproductive Toxicology Implementation Guide Version 1.2


name: Childhood Testicular Germ Cell Tumor by Toronto Guidelines v2 Stage


name: Childhood Testicular Germ Cell Tumor by Toronto Guidelines v2 Stage, Tier 1


name: Localized Childhood Testicular Germ Cell Tumor by Toronto Guidelines v2


name: Regional Childhood Testicular Germ Cell Tumor by Toronto Guidelines v2


name: Metastatic Childhood Testicular Germ Cell Tumor by Toronto Guidelines v2


name: Childhood Testicular Germ Cell Tumor by Toronto Guidelines v2 Stage, Tier 2


name: Stage I Childhood Testicular Germ Cell Tumor by Toronto Guidelines v2


name: Stage IA Childhood Testicular Germ Cell Tumor by Toronto Guidelines v2


name: Stage IB Childhood Testicular Germ Cell Tumor by Toronto Guidelines v2


name: Stage IS Childhood Testicular Germ Cell Tumor by Toronto Guidelines v2


name: Stage II Childhood Testicular Germ Cell Tumor by Toronto Guidelines v2


name: Stage IIA Childhood Testicular Germ Cell Tumor by Toronto Guidelines v2


name: Stage IIB Childhood Testicular Germ Cell Tumor by Toronto Guidelines v2


name: Stage IIC Childhood Testicular Germ Cell Tumor by Toronto Guidelines v2


name: Stage III Childhood Testicular Germ Cell Tumor by Toronto Guidelines v2


name: Stage IIIA Childhood Testicular Germ Cell Tumor by Toronto Guidelines v2


name: Stage IIIB Childhood Testicular Germ Cell Tumor by Toronto Guidelines v2


name: Stage IIIC Childhood Testicular Germ Cell Tumor by Toronto Guidelines v2


name: Childhood Ovarian Germ Cell Tumor by Toronto Guidelines v2 Stage


name: Childhood Ovarian Germ Cell Tumor by Toronto Guidelines v2 Stage, Tier 1


name: Localized Childhood Ovarian Germ Cell Tumor by Toronto Guidelines v2


name: Arsenic Trioxide/Gemtuzumab Ozogamicin/Tretinoin Regimen


name: Regional Childhood Ovarian Germ Cell Tumor by Toronto Guidelines v2


name: Arsenic Trioxide/Gemtuzumab Ozogamicin Regimen


name: Metastatic Childhood Ovarian Germ Cell Tumor by Toronto Guidelines v2


name: Childhood Ovarian Germ Cell Tumor by Toronto Guidelines v2 Stage, Tier 2


name: Stage I Childhood Ovarian Germ Cell Tumor by Toronto Guidelines v2


name: Stage II Childhood Ovarian Germ Cell Tumor by Toronto Guidelines v2


name: Stage III Childhood Ovarian Germ Cell Tumor by Toronto Guidelines v2


name: Stage IV Childhood Ovarian Germ Cell Tumor by Toronto Guidelines v2


name: Childhood Astrocytoma by Toronto Guidelines v2 Stage


name: Localized Childhood Astrocytoma by Toronto Guidelines v2


name: Metastatic Childhood Astrocytoma by Toronto Guidelines v2


name: Childhood Central Nervous System Embryonal Tumor by Toronto Guidelines v2 Stage


name: Childhood Central Nervous System Embryonal Tumor by Toronto Guidelines v2 Stage, Tier 1


name: Localized Childhood Central Nervous System Embryonal Tumor by Toronto Guidelines v2


name: Metastatic Childhood Central Nervous System Embryonal Tumor by Toronto Guidelines v2


name: Childhood Central Nervous System Embryonal Tumor by Toronto Guidelines v2 Stage, Tier 2


name: Stage M0 Childhood Central Nervous System Embryonal Tumor by Toronto Guidelines v2


name: Stage M1 Childhood Central Nervous System Embryonal Tumor by Toronto Guidelines v2


name: Stage M2 Childhood Central Nervous System Embryonal Tumor by Toronto Guidelines v2


name: Stage M3 Childhood Central Nervous System Embryonal Tumor by Toronto Guidelines v2


name: Stage M4 Childhood Central Nervous System Embryonal Tumor by Toronto Guidelines v2


name: Childhood Medulloblastoma by Toronto Guidelines v2 Stage


name: Childhood Medulloblastoma by Toronto Guidelines v2 Stage, Tier 1


name: Localized Childhood Medulloblastoma by Toronto Guidelines v2


name: Metastatic Childhood Medulloblastoma by Toronto Guidelines v2


name: Childhood Medulloblastoma by Toronto Guidelines v2 Stage, Tier 2


name: Stage M0 Childhood Medulloblastoma by Toronto Guidelines v2


name: Stage M1 Childhood Medulloblastoma by Toronto Guidelines v2


name: Stage M2 Childhood Medulloblastoma by Toronto Guidelines v2


name: Stage M3 Childhood Medulloblastoma by Toronto Guidelines v2


name: Stage M4 Childhood Medulloblastoma by Toronto Guidelines v2


name: Childhood Ependymoma by Toronto Guidelines v2 Stage


name: Childhood Ependymoma by Toronto Guidelines v2 Stage, Tier 1


name: Localized Childhood Ependymoma by Toronto Guidelines v2


name: Metastatic Childhood Ependymoma by Toronto Guidelines v2


name: Childhood Ependymoma by Toronto Guidelines v2 Stage, Tier 2


name: Stage M0 Childhood Ependymoma by Toronto Guidelines v2


name: Stage M1 Childhood Ependymoma by Toronto Guidelines v2


name: Stage M2 Childhood Ependymoma by Toronto Guidelines v2


name: Stage M3 Childhood Ependymoma by Toronto Guidelines v2


name: Stage M4 Childhood Ependymoma by Toronto Guidelines v2


name: High-dose Cytarabine/Gemtuzumab Ozogamicin Regimen


name: Paid for Tests or Examinations Performed During or Following Consultations


name: Medical Product or Procedure Usage and Evaluation


name: Medical Product or Procedure Limitation of Use


name: Regimen Used to Treat Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma


name: Samples for Toxicokinetic Analysis Indicator


name: CDISC Clinical Classification Harvey-Bradshaw Index HBI0101 Original Response Terminology


name: Elective Percutaneous Coronary Intervention


name: Homology-Directed DNA Repair Frequency Measurement


name: Have Someone to Talk with When Having a Bad Day


name: Adaptation or Revision of Treatment Plan


name: Sliding Window Radiation Therapy Delivery Method


name: Classical Monocyte to Monocyte Ratio Measurement


name: HUGO Gene Nomenclature Committee, 2023_04


name: Assessment using IDDSI-FDS (International Dysphagia Diet Standardisation Initiative Functional Diet Scale)


name: IDDSI-FDS - International Dysphagia Diet Standardisation Initiative Functional Diet Scale


name: IDDSI-FDS (International Dysphagia Diet Standardisation Initiative Functional Diet Scale) score


name: International Dysphagia Diet Standardisation Initiative Framework - Thin Level 0


name: IDDSI (International Dysphagia Diet Standardisation Initiative) Framework levels


name: Replacement of cardiac resynchronization therapy defibrillator pulse generator


name: International Dysphagia Diet Standardisation Initiative Framework - Slightly Thick Level 1


name: International Dysphagia Diet Standardisation Initiative Framework - Mildly Thick Level 2


name: International Dysphagia Diet Standardisation Initiative Framework - Moderately Thick Level 3


name: International Dysphagia Diet Standardisation Initiative Framework - Liquidized Level 3


name: International Dysphagia Diet Standardisation Initiative Framework - Extremely Thick Level 4


name: International Dysphagia Diet Standardisation Initiative Framework - Pureed Level 4


name: International Dysphagia Diet Standardisation Initiative Framework - Minced & Moist Level 5


name: International Dysphagia Diet Standardisation Initiative Framework - Soft & Bite Sized Level 6


name: International Dysphagia Diet Standardisation Initiative Framework - Easy to Chew Level 7


name: International Dysphagia Diet Standardisation Initiative Framework - Regular Level 7


name: Assessment using IDDSI (International Dysphagia Diet Standardisation Initiative) Framework


name: IDDSI (International Dysphagia Diet Standardisation Initiative) Framework


name: IDDSI (International Dysphagia Diet Standardisation Initiative) Framework drinks level


name: IDDSI (International Dysphagia Diet Standardisation Initiative) Framework food level


name: Presence of regression of primary malignant neoplasm after neoadjuvant antineoplastic therapy


name: Presence of regression of primary malignant neoplasm of breast after neoadjuvant antineoplastic therapy


name: Presence of regression of primary malignant gastrointestinal stromal sarcoma after neoadjuvant antineoplastic therapy


name: Presence of regression of primary malignant neoplasm of central nervous system after neoadjuvant antineoplastic therapy


name: Presence of regression of primary malignant neoplasm of anus after neoadjuvant antineoplastic therapy


name: Presence of regression of primary malignant neoplasm of esophagus after neoadjuvant antineoplastic therapy


name: Presence of regression of primary malignant neoplasm of liver after neoadjuvant antineoplastic therapy


name: Presence of regression of primary malignant neoplasm of pancreas after neoadjuvant antineoplastic therapy


name: Presence of regression of primary malignant neoplasm of stomach after neoadjuvant antineoplastic therapy


name: Presence of regression of primary malignant neoplasm of prostate after neoadjuvant antineoplastic therapy


name: Presence of regression of primary malignant neoplasm of ovary after neoadjuvant antineoplastic therapy


name: Presence of regression of primary malignant neoplasm of fallopian tube after neoadjuvant antineoplastic therapy


name: Presence of regression of primary malignant neoplasm of lung after neoadjuvant antineoplastic therapy


name: Presence of regression of primary malignant neoplasm of thymus after neoadjuvant antineoplastic therapy


name: Presence of regression of primary malignant neoplasm of bone after neoadjuvant antineoplastic therapy


name: Presence of regression of primary malignant neoplasm of soft tissue after neoadjuvant antineoplastic therapy


name: Presence of regression of primary malignant neoplasm of peritoneum after neoadjuvant antineoplastic therapy


name: Presence of regression of primary malignant melanoma of skin


name: Presence of regression of primary malignant mesothelioma after neoadjuvant antineoplastic therapy


name: Presence of mast/stem cell growth factor receptor Kit in primary gastrointestinal stromal sarcoma by immunohistochemistry


name: Presence of anoctamin-1 in primary gastrointestinal stromal sarcoma by immunohistochemistry


name: Presence of succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial in primary gastrointestinal stromal sarcoma by immunohistochemistry


name: Presence of succinate dehydrogenase [ubiquinone] iron-sulfur subunit, mitochondrial in primary gastrointestinal stromal sarcoma by immunohistochemistry


name: Histologic architectural pattern (property)


name: Histologic architectural pattern in adenocarcinoma of lung


name: Histologic architectural pattern in ductal carcinoma in situ of breast


name: International Dysphagia Diet Standardisation Initiative Framework - Easy to Chew Level 7 food


name: International Dysphagia Diet Standardisation Initiative Framework - Extremely Thick Level 4 drinks


name: International Dysphagia Diet Standardisation Initiative Framework - Liquidized Level 3 food


name: International Dysphagia Diet Standardisation Initiative Framework - Mildly Thick Level 2 drinks


name: International Dysphagia Diet Standardisation Initiative Framework - Minced and Moist Level 5 food


name: International Dysphagia Diet Standardisation Initiative Framework - Moderately Thick Level 3 drinks


name: International Dysphagia Diet Standardisation Initiative Framework - Pureed Level 4 food


name: International Dysphagia Diet Standardisation Initiative Framework - Regular Level 7 food


name: International Dysphagia Diet Standardisation Initiative Framework - Slightly Thick Level 1 drinks


name: International Dysphagia Diet Standardisation Initiative Framework - Soft and Bite Sized Level 6 food


name: Surgical margin closest to primary malignant neoplasm in excised specimen of pancreas


name: Histologic grade of primary malignant neoplasm of ampulla of Vater


name: Number of metastatic discontinuous tumor deposits of primary malignant neoplasm of appendix


name: Presence of regression of primary malignant neoplasm of colon after neoadjuvant antineoplastic therapy


name: Surgical margin closest to primary malignant neoplasm of extraheptic bile duct in excised specimen


name: Histologic grade of primary malignant neoplasm of urinary bladder


name: Presence of regression of metastatic neoplasm of breast in lymph node after neoadjuvant antineoplastic therapy


name: Open instillation of substance into abdominal cavity


name: International Dysphagia Diet Standardisation Initiative Framework - Thin Level 0 drinks


name: World Health Organization and International Society of Urological Pathology grading system for renal cell carcinoma


name: Histologic grade of renal cell carcinoma by World Health Organization and International Society of Urological Pathology technique


name: Scaling of teeth with root planing in quadrant of dental arch


name: Maternal antenatal and/or intrapartum and/or postpartum period


name: Prosthetic reinforcement of extra-articular ligament


name: Mesalamine 1.5 g prolonged-release oral granules sachet


name: Open reduction of fracture of right iliac spine with internal fixation


name: Open reduction of fracture of left iliac spine with internal fixation


name: Mesalamine 3 g prolonged-release oral granules sachet


name: Mesalamine 500 mg prolonged-release oral granules sachet


name: Maternal antepartum and/or intrapartum and/or postpartum period


name: Repair of ventral hernia using robotic assistance


name: Laparoscopic repair of paraumbilical hernia using synthetic mesh


name: Laparoscopic repair of paraumbilical hernia


name: Endoscopic transurethral removal of tension free vaginal tape from urethra


name: Endoscopic transurethral removal of tension free vaginal tape from bladder


name: Endoscopic transurethral removal of transobturator tape from urethra


name: Endoscopic transurethral removal of transobturator tape from bladder


name: Extracorporeal irradiation of tumor bearing bone and reimplantation


name: Scleral reinforcement surgery balloon catheter


name: Bronchial radiofrequency thermoplasty system catheter


name: Facial muscle cosmesis electrical stimulator


name: Colonoscopic control of rectal bleeding using electrocoagulation


name: Proctoscopic control of rectal bleeding using electrocoagulation


name: Laparoscopic repair of paraumbilical hernia using biological mesh


name: Potassium citrate 3 g granules for oral solution sachet


name: Dexketoprofen (as dexketoprofen tromethamine) 25 mg granules for oral solution sachet


name: Imipramine hydrochloride 75 mg oral tablet


name: Removal of intrauterine contraceptive device from uterine cavity


name: Reconstruction of breast using free superficial inferior epigastric artery flap


name: Reconstruction of breast using free lumbar artery perforator flap


name: Reconstruction of breast using free profunda artery perforator flap


name: Reconstruction of breast using free transverse upper gracilis flap


name: Xylometazoline hydrochloride 140 microgram/actuation nasal spray


name: Excision of part of right breast and lymph node group of right axilla


name: Excision of part of left breast and lymph node group of left axilla


name: Isavuconazole (as isavuconazonium sulfate) 200 mg powder for solution for infusion vial


name: Somatropin 6.667 mg/mL solution for injection


name: Lenograstim 33.6 million unit powder for solution for infusion vial


name: Sodium chloride 9 mg/mL solution for infusion


name: Cardiac resynchronization therapy defibrillator pulse generator


name: Esophagogastroduodenoscopic electrohydraulic lithotripsy of bezoar in stomach


name: Robot assisted subtotal gastrectomy with abdominal lymphadenectomy


name: Colonoscopic decompression of large intestine


name: Reconstruction of breast using chest wall perforator flap


name: Reconstruction of breast using pedicled lateral intercostal artery perforator flap


name: Reconstruction of breast using pedicled anterior intercostal artery perforator flap


name: Reconstruction of breast using pedicled thoracodorsal artery perforator flap


name: Reconstruction of breast using pedicled lateral thoracic artery perforator flap


name: Laparoscopic plication of greater curvature of stomach


name: Fitting of lower fixed orthodontic retainer


name: Fitting of acrylic removable partial denture


name: Endoscopic control of hemorrhage of stomach using argon plasma coagulation


name: Delayed repair of tendon using tendon transfer


name: Delayed repair of tendon using temporary prosthesis


name: Delayed repair of tendon using permanent prosthesis


name: Delayed repair of tendon to bone using fixation


name: Delayed repair of tendon using lengthening procedure


name: Restoration of tooth using ceramic onlay


name: Replacement of fixed orthodontic retainer


name: Fiberoptic endoscopic coagulation of hemorrhage of upper gastrointestinal tract using hemostatic spray


name: Fiberoptic endoscopic coagulation of hemorrhage of esophagus using hemostatic spray


name: Revision of one component of prosthetic hybrid replacement of shoulder joint using cemented humeral component


name: Revision of one component of hybrid prosthetic replacement of shoulder joint using cement


name: Revision of one component of prosthetic hybrid replacement of shoulder joint using cemented glenoid component


name: Revision of one component of hybrid reverse polarity prosthetic replacement of shoulder joint using cement


name: Replacement of breast prosthesis in pre-pectoral space


name: Laparoscopic plication of uterosacral ligament


name: Removal of breast prosthesis from pre-pectoral space


name: Fiberoptic endoscopic cryoablation of lesion of colon


name: Implantation of personalized external aortic root support


name: Endoscopic control of hemorrhage of duodenum using argon plasma coagulation


name: Excision of rectum by TEM (transanal endoscopic microsurgery)


name: Transanal endoscopic microsurgery rectoscope


name: Implantation of osseointegrated bone anchor into bone of face


name: Custom made aortic root extraluminal mesh-sleeve


name: Restoration of tooth using composite resin onlay


name: High resolution anoscopic ablation of lesion of anal region


name: Fitting of removable partial denture with cobalt chromium framework


name: Restoration of tooth using composite resin crown


name: Drug coated peripheral artery endovascular stent graft


name: Internal gastrointestinal vibratory stimulation system


name: Internal gastrointestinal vibratory stimulation system capsule


name: Radioligand therapy using lutetium (Lu-177) vipivotide tetraxetan


name: Ganglion impar block with chemical neurolysis


name: Insertion of Michigan appliance onto maxillary teeth


name: Insertion of custom soft interocclusal splint


name: Ataluren-containing product in oral dose form


name: Minocycline-containing product in dental dose form


name: Minocycline only product in dental dose form


name: Sodium chloride 9 mg/mL solution for infusion and/or injection


name: Excision of mass of breast using hooked wire guidance


name: Fitting of upper fixed orthodontic retainer


name: Removal of residual dental adhesive from tooth


name: Removal of residual dental cement from tooth


name: Insertion of fixed orthodontic appliance onto maxillary teeth


name: Insertion of fixed orthodontic appliance onto mandibular teeth


name: Topical application of hydrogen peroxide to discolored vital teeth using teeth whitening tray


name: Topical application of hydrogen peroxide to discolored non-vital teeth using teeth whitening tray


name: Percentage of nephroblastoma involved by necrosis in excised kidney specimen


name: Excision of lesion of rectum by TAMIS (transanal minimal invasive surgery)


name: Histologic type of nephrogenic rest in primary nephroblastoma


name: Presence of nephrogenic rests in primary nephroblastoma


name: Endoscopic ultrasonography guided gastrojejunostomy and insertion of stent


name: Trientine (as trientine hydrochloride) 200 mg oral capsule


name: Insertion of maxillary obturator with cobalt chromium framework


name: Epinephrine 100 microgram/mL solution for injection


name: Follow-up for combined therapy of radiation therapy and chemotherapy


name: Follow-up for combined therapy of surgery and chemotherapy


name: Follow-up for combined therapy of surgery and radiation therapy


name: Follow-up for combined therapy of surgery, radiation therapy, and chemotherapy


name: Insertion of maxillary surgical obturator


name: Insertion of indirect restoration onto tooth


name: Fixation of indirect restoration to tooth


name: Carbomer-974P only product in ocular dose form


name: Carbomer-974P-containing product in ocular dose form


name: Endoscopic ultrasonography guided cholecystoduodenostomy and insertion of stent


name: Diclofenac sodium (as diclofenac diethylammonium) 20 mg/g cutaneous gel


name: Carbenoxolone-containing product in cutaneous dose form


name: Carbenoxolone only product in cutaneous dose form


name: Etofenamate only product in cutaneous dose form


name: Brimonidine only product in cutaneous dose form


name: Isavuconazole (as isavuconazonium sulfate) 200 mg powder for solution for infusion and/or injection vial


name: Amlexanox only product in oromucosal dose form


name: Carbenoxolone only product in oromucosal dose form


name: Choline salicylate only product in oromucosal dose form


name: Choline salicylate-containing product in oromucosal dose form


name: Carboxymethylcellulose only product in oromucosal dose form


name: Number of primary malignant neoplasms in excised tissue specimen


name: Presence of direct invasion by malignant melanoma of skin to lymphatic vessel and/or small blood vessel


name: Presence of neurotropism in malignant melanoma of skin


name: Presence of microsatellite of malignant melanoma


name: Fixation of indirect restoration to tooth using silicate cement


name: Restoration of tooth using porcelain fused to noble metal crown


name: Implantation of prosthesis into joint of right wrist


name: Implantation of prosthesis into joint of left wrist


name: Imaging guided core needle biopsy of breast


name: Imaging guided vacuum assisted biopsy of breast


name: Presence of ulcer in primary malignant melanoma of skin


name: Presence of metastatic neoplasm in lymph node in excised tissue specimen


name: Qualitative distribution of primary malignant neoplasm of colon in colectomy specimen


name: Stereotactically guided fine needle aspiration biopsy of breast


name: Isavuconazole (as isavuconazonium sulfate) 100 mg oral capsule


name: Implantation of prosthesis into joint of left ankle


name: Implantation of prosthesis into joint of right ankle


name: Implantation of prosthesis into ankle joint


name: Assessment using Basic Periodontal Examination


name: Replacement of dental implant prosthetic screw


name: Replacement of dental precision attachment


name: Percutaneous drainage of lymphatic system using imaging guidance


name: Laparoscopic dissection of para-aortic lymph node group


name: Ipratropium bromide 250 microgram/mL solution for nebulizer


name: Methotrexate 25 mg/mL solution for injection


name: Methotrexate 50 mg/mL solution for injection


name: Endoscopic ultrasonography guided hepaticogastrostomy and insertion of biliary stent


name: Cetuximab 5 mg/mL solution for infusion and/or injection


name: Endoscopic ultrasonography guided cystogastrostomy of pancreas and insertion of stent


name: Dexamethasone phosphate (as dexamethasone sodium phosphate) 4 mg/mL solution for infusion


name: Dexamethasone phosphate (as dexamethasone sodium phosphate) 4 mg/mL solution for infusion and/or injection


name: Endoscopic ultrasonography guided choledochoduodenostomy and insertion of biliary stent


name: Indacaterol (as indacaterol maleate) 300 microgram/actuation powder for inhalation


name: Albuterol (as albuterol sulfate) 1 mg/mL solution for nebulizer


name: Deep surgical margin closest to Merkel cell carcinoma of skin in excised skin specimen


name: Peripheral surgical margin closest to Merkel cell carcinoma of skin in excised skin specimen


name: Presence of direct invasion by primary Merkel cell carcinoma of skin to lymphatic vessel and/or small blood vessel


name: Glucose 50 mg/mL solution for infusion and/or injection


name: Diroximel fumarate only product in oral dose form


name: Filgrastim (as lipegfilgrastim) 10 mg/mL solution for injection


name: Lipegfilgrastim only product in parenteral dose form


name: Leuprolide (as leuprolide acetate) 5 mg prolonged-release subcutaneous implant


name: Excision of aneurysm of right cardiac ventricle


name: Histologic grade of primary malignant neoplasm of stomach


name: Lauren classification of adenocarcinoma in stomach


name: World Health Organization classification of adenocarcinoma in stomach fifth edition


name: Histologic type of primary adenocarcinoma of stomach using Lauren classification technique


name: Histologic type of primary adenocarcinoma of stomach using World Health Organization fifth edition technique


name: Histologic grade of primary malignant neoplasm of vagina


name: Histologic grade of primary malignant neoplasm of vulva


name: Benzydamine hydrochloride 1.5 mg/mL oromucosal solution


name: Cycle threshold for nucleic acid detection in specimen using real-time polymerase chain reaction


name: Coordination of resources to address social needs


name: Coordination of resources to address intimate partner abuse


name: Coordination of resources to address elder abuse


name: Insertion of resin modified glass ionomer cement into tooth


name: Fixation of temporary dental crown to dental implant


name: Cementation of restoration to dental implant


name: Fitting of restoration to dental implant


name: Surgical removal of peritoneal dialysis catheter


name: Lamivudine- and tenofovir-containing product


name: Lamivudine- and tenofovir-containing product in oral dose form


name: Lamivudine and tenofovir only product in oral dose form


name: Aspirin and glycine only product in oral dose form


name: Coordination of resources to address inadequate housing


name: Assistance with application for vocational rehabilitation program


name: Assistance with application for vocational education program


name: Insertion of tooth supported radiographic dental implant stent


name: Insertion of oral soft tissue supported radiographic dental implant stent


name: Assistance with completing documentation to assign power of attorney


name: Valproate sodium 66.66 mg and valproic acid 29.03 mg prolonged-release oral granules sachet


name: Immune status determined by history of disease


name: Diphtheria immune status determined by serology


name: Valproate sodium 166.76 mg and valproic acid 72.61 mg prolonged-release oral granules sachet


name: Valproate sodium 333.3 mg and valproic acid 145.14 mg prolonged-release oral granules sachet


name: Stand-assistive attendant only propelled wheelchair


name: Gastrointestinal radiofrequency ablation system catheter


name: Haemophilus influenzae type b immune status


name: Haemophilus influenzae type b immune status determined by serology


name: Measles immune status determined by serology


name: Meningococcus immune status determined by serology


name: Polio immune status determined by serology


name: Rabies immune status determined by serology


name: Varicella immune status determined by serology


name: Mumps immune status determined by serology


name: Pertussis immune status determined by serology


name: Tetanus immune status determined by serology


name: Lyme immune status determined by serology


name: Sevoflurane 999 microliter/mL solution for inhalation


name: Magnesium (as magnesium aspartate) 121.56 mg powder for oral solution sachet


name: Histologic grade of primary malignant neoplasm of stomach using World Health Organization classification of tumors system fifth edition method


name: Ultrasonography guided insertion of radiofrequency identifier tag into breast


name: Simple mastectomy of right breast and prophylactic mastectomy of left breast


name: Mammography guided insertion of infrared reflector into breast


name: Wide local excision of lesion of breast using infrared reflector


name: Digital tomosynthesis guided insertion of infrared reflector localization marker into breast


name: Excisional biopsy of lesion of breast using infrared reflector


name: Ultrasonography guided insertion of infrared reflector localization marker into breast


name: Mammography guided insertion of guide wire into breast


name: Targeted temperature management following cardiac arrest


name: Simple mastectomy of left breast and prophylactic mastectomy of right breast


name: Wide local excision of lesion of breast using radiofrequency identifier tag


name: Digital breast tomosynthesis guided insertion of radiofrequency identifier tag into breast


name: Interferon beta-1a 60 microgram/mL solution for injection


name: Pancreatic amylase and pancreatic lipase and pancreatic protease only product in oral dose form


name: Pancreatic amylase and pancreatic lipase and pancreatic protease only product


name: Complementary and alternative medicine center


name: Porous impregnated material for pulmonary vapor inhalation


name: Porous impregnated material for oromucosal vapor inhalation


name: Replacement of Hawley orthodontic retainer


name: Replacement of vacuum formed orthodontic retainer


name: Dimethicone;Lidocaine 5%; 5% Multiple Routes Kit [DERMAZYL]


name: skin cleanser combination no.10 TOPICAL CLEANSER (ML)


name: skin cleanser combination no.43 TOPICAL CLEANSER (ML)


name: AVOBENZONE 18 mg in 1 mL / HOMOSALATE 70 mg in 1 mL / OCTOCRYLENE 50 mg in 1 mL TOPICAL LOTION [Aldi LACURA SPORT Sunscreen 30 Broad Spectrum SPF 30]


name: AVOBENZONE 30 mg in 1 g / HOMOSALATE 100 mg in 1 g / OCTISALATE 50 mg in 1 g / OCTOCRYLENE 20 mg in 1 g TOPICAL SPRAY [Aldi LACURA Sport Sunscreen 30 Broad Spectrum SPF 30 Continuous]


name: AVOBENZONE 30 mg in 1 g / HOMOSALATE 100 mg in 1 g / OCTISALATE 50 mg in 1 g / OCTOCRYLENE 40 mg in 1 g TOPICAL SPRAY [Aldi LACURA Sport Sunscreen 50 Broad Spectrum SPF 50 Continuous]


name: AVOBENZONE 30 mg in 1 g / HOMOSALATE 150 mg in 1 g / OCTISALATE 50 mg in 1 g / OCTOCRYLENE 100 mg in 1 g / OXYBENZONE 60 mg in 1 g TOPICAL SPRAY [Aldi Lacura Ultra Light Body SPF 100]


name: OCTINOXATE 7 g in 100 mL / ZINC OXIDE 6 g in 100 mL TOPICAL LOTION [Daily Moisturizer Sunscreen Broad Spectrum SPF 25]


name: OCTOCRYLENE 10 g in 100 mL / ZINC OXIDE 10.13 g in 100 mL TOPICAL LOTION [First Aid Beauty FAB Ultra Repair Face Moisturizer with Sunscreen Broad Spectrum SPF 30]


name: TITANIUM DIOXIDE 1.33 g in 100 mL / ZINC OXIDE 17.42 g in 100 mL TOPICAL CREAM [Mineral Mattescreen SPF 40]


name: TITANIUM DIOXIDE 49 mg in 1 mL / ZINC OXIDE 47 mg in 1 mL TOPICAL LOTION [CVS Health 60 Plus Sensitive Skin Sun]


name: ZINC OXIDE 145 mg in 1 mL / OCTISALATE 50 mg in 1 mL TOPICAL LOTION [ALDI LACURA KIDS SUNSCREEN MINERAL BASED SPF 50]


name: ZINC OXIDE 16 g in 100 mL TOPICAL CREAM [Mineral Broad Spectrum Sunscreen]


name: ZINC OXIDE 16.32 g in 100 mL TOPICAL LOTION [OLE HENRIKSEN BANANA BRIGHT MINERAL SUNSCREEN SPF 30]


name: ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY 15 g in 100 g TOPICAL STICK [Secret Cool Waterlily Invisible]


name: AVOBENZONE 30 mg in 1 mL / HOMOSALATE 100 mg in 1 mL / OCTOCRYLENE 60 mg in 1 mL TOPICAL LOTION [Aldi LACURA SPORT Sunscreen 50 Broad Spectrum SPF 50]


name: AVOBENZONE 30 mg in 1 mL / HOMOSALATE 150 mg in 1 mL / OCTISALATE 50 mg in 1 mL / OCTOCRYLENE 100 mg in 1 mL / OXYBENZONE 60 mg in 1 mL TOPICAL LOTION [Aldi LACURA Ultra Light Dry-Touch 100 Sunscreen]


name: HOMOSALATE 150 mg in 1 g / AVOBENZONE 20 mg in 1 g / OCTISALATE 50 mg in 1 g TOPICAL STICK [CVS Health Oil Free Broad Spectrum SPF 30]


name: {1 (acetaminophen 21.7 MG/ML / dextromethorphan hydrobromide 0.667 MG/ML Oral Solution) / 1 (acetaminophen 21.7 MG/ML / dextromethorphan hydrobromide 1 MG/ML / doxylamine succinate 0.417 MG/ML Oral Solution) } Pack


name: ALUMINUM ZIRCONIUM PENTACHLOROHYDREX GLY 16.3 g in 96 mL TOPICAL LIQUID


name: ZINC OXIDE 250 mg in 1 g TOPICAL POWDER [Colorlogix Clear and Sheer]


name: ZINC OXIDE 14 g in 100 mL TOPICAL SPRAY [SOLARA SUNCARE - GO MINERAL DEFENSE SPORT SUPERFRUIT VITAMIN C PLUS ALOE SHEER SUNSCREEN MIST SPF-30 UNSCENTED]


name: AVOBENZONE 3 g in 100 g / OCTOCRYLENE 10 g in 100 g / HOMOSALATE 15 g in 100 g / OCTISALATE 5 g in 100 g TOPICAL LOTION [QC SPF 50 Sunscreen]


name: AVOBENZONE 3 g in 100 g / OCTOCRYLENE 6 g in 100 g / HOMOSALATE 15 g in 100 g / OCTISALATE 5 g in 100 g TOPICAL LOTION [QC SPF 30 Sunscreen]


name: OCTINOXATE 6.9 g in 100 mL / OCTISALATE 3 g in 100 mL / ZINC OXIDE 4 g in 100 mL TOPICAL CREAM [AROMA MATTE DAY SUNSCREEN SPF-30]


name: OCTINOXATE 7 g in 100 mL / ZINC OXIDE 6 g in 100 mL TOPICAL LOTION [Defense Broad Spectrum SPF 25 Sunscreen]


name: ROMIFIDINE HYDROCHLORIDE 1 kg in 1 kg NOT APPLICABLE POWDER [Romifidine HCl]